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CHAPTER ONE 
REVIEW OF METAL CATALYZED ALKYLIDENECYCLOPROPANE 
BISFUNCTIONALIZATIONS 
Introduction
The study of the chemistry of olefins has been a staple in the development of modern 
synthetic organic chemistry.  Reactions of olefins have advanced and been applied to more 
complex unsaturated functionalities (e.g. alkynes, allenes, dienes, ,-unsaturated carbonyls), 
yet, until recently strained unsaturated systems have gone underexplored.  By incorporating the 
relief of ring strain into the reactivity of olefins, the activity of the olefin is increased, and is 
capable of undergoing reactions and rearrangements which are unavailable to traditional olefins 
(Scheme 1)1.  Of these strained unsaturated compounds, the versatile alkylidenecyclopropane 
(ACP) moiety has only received considerable attention in the last two decades. 
Scheme 1. Versatile Reactivity of ACPs Under Metal-Catalyzed Conditions 
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By harnessing the potential energy of the strained ACP system, structurally complex 
molecules can be more easily accessed through olefins chemistry.  Unlike olefins, the 
alkylidenecyclopropane is capable of undergoing various 1,2-, as well as, 1,3-additions.  Due to 
the high ring strain of the ACPs, cleavage of the ring often occurs under metal-catalyzed, acidic, 
radical, or thermal conditions; this allows for a variety of products to be furnished from a single 
substrate, making ACPs a natural branching point for further synthetic manipulation. 
There have been several well written reviews encompassing ACP rearrangements, cycloaddition 
chemistry, and hydrofunctionalizations, thus these topics will not be included in this review. 2–6  
However, an aggregation of bisfunctionalization methodology with regards to 
alkylidenecyclopropanes is lacking from the literature.  Therefore, a review encompassing recent 
advancements in the bisfunctionalization of ACPs is essential to showcase their synthetic 
potential. 
Metal-Catalyzed bisfunctionalization of ACPs 
The most diverse types of ACP bisfunctionalizations fall under the category of metal-
catalyzed bisfunctionalizations.  Transition metal chemistry offers many powerful C-C or C-Y 
bond formation techniques for molecular transformations of ACPs.1  Furthermore, the electron 
rich structure of the cyclopropane ring make ACPs are ideal candidates for transition metal 
catalysis.  Due to their unique reactivity, transition metal catalyzed ACP functionalizations have 
also been strategically employed to access a variety of heterocyclic scaffolds and highly 
substituted synthetic intermediates.2,6,7 
The ACP unit is known for its versatility and ability to create molecular complexity via 
its reactivity pathways.  However, most of the widely reported ACP functionalizations are 
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hydrofunctionalizations, rearrangements, or cycloadditions.  Each of these aforementioned 
reactions are inherently limited in some way: hydrofunctionalizations form a C-H bond from a 
functionalizable C-[M] intermediate; rearrangements are limited by their unpredictability and 
need to synthesize new starting materials to create libraries of molecules; and cycloadditions are 
limited to -containing components.  By applying bisfunctionalization methodology to 
alkylidenecyclopropanes, organic chemists will find ACPs to be unique and powerful synthetic 
branch points. 
Early Examples of ACP Bisfunctionalization 
Initial work in the area of metal catalyzed ACP bisfunctionalization began in 1988 with 
Chatani and coworker’s investigation into the intermolecular Ni- and Pd-catalyzed couplings of 
ACPs 1 with silyl cyanides to yield substituted alkenes 2 and substituted cyclopropanes 3 
(Scheme 2).8   
Scheme 2. Silylcyanation of ACPs with Metal Dependent Regioselectivity 
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Product distribution could be controlled by choice of metal catalyst.  Pd-catalysis 
preferred cyclopropane cleavage, whereas Ni-catalysis favored addition of the silyl cyanide to 
the olefin of the ACP.  With either catalyst system, disubstituted ACPs 6 and 7 were unreactive.  
While these first reactions yielded interesting synthetic intermediates, their utility is limited by 
highly variable yields as well as poor control over the resulting olefin’s stereochemistry. 
These initial reports were followed up by Fournet’s survey of various intermolecular and 
intramolecular Pd-catalyzed couplings of ACPs.9  These reports demonstrated the ability of ACP 
bisfunctionalization to form interesting carbon frameworks via the simultaneous addition of 
vinyl bromides or aryl iodides paired and malonate derived nucleophiles to a simple ACP 
(Scheme 3).  An attempt to apply this methodology toward cyclohexane fused ACP 12 led only 
to coupling of the aryl iodide followed by -hydride elimination to yield cyclohexene products 
13-15. 
Scheme 3. Pd-Catalyzed Intermolecular Bisfunctionalization of ACPs 
 
 Fournet then demonstrated the scope of this reaction by forming carbocyclic scaffolds 17 
and 18, as well as a substituted pyrrolidine products 20 and 21, through an intramolecular attack 
of the nucleophile (Scheme 4).10,11  The authors propose that these transformations proceed 
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through -allyl complexes of structure 22, beginning with a carbopalladation bond forming event 
followed by cyclization of the internal nucleophile. 
Scheme 4. Pd-Catalyzed Bisfunctionalization of ACPs with an Internal Nucleophile 
 
Recent Advances 
These initial reports from the Chatani and Fournet groups showed proof of concept for 
the bisfunctionalization of ACPs.  From there, several groups have made efforts to utilize ACP 
bisfunctionalization methodology to form advanced synthetic intermediates (such as substituted 
-halo alcohols)12 or challenging heterocycles (such as substituted azepanes or congested 
pyrrolidines).13,14  This review will organize the reactions by the types of bonds formed in the 
metal-catalyzed bisfunctionalization reaction. 
C-X, C-Y bond forming reactions.  The formation of two new heteroatom bonds across an 
ACP has received moderate attention in the past two decades.  In 1999, Miyaura and coworkers 
developed a method for the bis-borylation of ACPs under Pt-catalyzed conditions as an effective 
route toward functionalized synthetic intermediates(Scheme 5).15  The addition of the two boron 
functionalities to ACPs, under Pt-catalyzed conditions, occurs selectively though a proximal 
bond cleavage of the cyclopropane to yield a product containing both alkyl and vinyl boranes; 
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these functionalities can be selectively manipulated to provide highly functionalized synthetic 
building blocks, such as substituted styrene 28.   
Scheme 5. Pt-Catalyzed Bisborylaytion of ACPs and Product Utility 
 
A more thorough survey of the synthetic potential of ACP bisfunctionalization was 
conducted by Suginome et al.16  Dictated by choice of metal, palladium or platinum, the authors 
demonstrated regioselective additions/ring cleavages of ACPs to form new carbon-boron and 
carbon-silicon bonds with high E-Z selectivity (Scheme 6).  By employing ACP 30a and a Pd-
catalyst, the Z-olefin, 31a was formed preferentially; however, when ACP 30b was employed no 
reaction occurs.  Opposite selectivity was observed when a Pt-catalyst was used, preferentially 
forming the E-isomer, even with ACP 30b. 
Scheme 6. Regioselective Borosilyation of Aryl ACPs 
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Employing cycloalkyl derived ACPs (33) under the same reaction conditions yielded 
different regioselectivity compared to ACPs of structure 30. Selective bond cleavage was 
obtained by varying the metal catalyst (Scheme 7). 
Scheme 7. Regioselective Borosilylation of Cycloalkyl ACPs 
 
 
For ACPs of structure 33, distal bond cleavage was observed under Pd-catalyzed conditions 
yielding product 34, whereas Pt-catalysis yielded compounds of structure 35 via proximal bond 
cleavage.  When applying the same methodology to ACP 35 the proximal bond cleavage product 
36 was obtained under Pd-catalyzed conditions, while Pt-catalysis led to product 37.  The 
formation of compound 37 is hypothesized to arise from -hydride elimination and reinsertion of 
the Pt-catalyst in the opposite orientation.  An enantiospecific variation of this process was 
developed several years later by employing chiral phosphine ligand 40 to give rise to valuable 
synthetic intermediate 39 (Scheme 8).17 Later, the authors applied this method to the use of 
polymeric phosphine ligands which enhanced the ee of the transformation to 90-95%; as little as 
0.2 mol % Pd efficiently catalyzed the reaction.18 
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Scheme 8. Desymmiterization of meso-ACPs via Pd-Catalyzed Borosilylation 
 
An attempt by Suginome et al. to apply this methodology to non-meso ACP 41 in order to 
derive a kinetic resolution method, toward these interesting synthetic intermediates, showed 
moderate success (Scheme 9).19  Good enantioinduction was observed in the formation of 
products 42 and 43.  However to obtain selectivity in this reaction, a threefold excess of the ACP 
must be employed (relative to the silyl borane) to achieve good enantioselectivity and 
regioselectivity. 
Scheme 9. Kenetic Resolution of Substituted ACPs via Pd- Catalyzed Borosilyation 
 
Due to the difficulty in selecting between products 42 and 43, a site-selective method to 
access these intermediates was demanded.20  By employing a Pt-catalyst under ligand free 
conditions, with the more sterically demanding silylborane 45, these substituted ACPs could be 
reacted with 100% regioselectivity to yield a racemic mixture of the silyl borylated product 46 
(Scheme 10). 
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Scheme 10. Site Selective Pt-catalyzed borosilylation of  substituted ACPs 
 
 A highly stereoselective aminoborylation reaction of ACPs under copper catalyzed 
conditions was described by Miura and Hirano (Scheme 11).  There is retention of the 
cyclopropane ring throughout the reaction, and the substituents on the ring play a large role in 
the stereochemical outcome of the transformation. 
Scheme 11. Cu-Catalyzed Aminoborylation of ACPs 
 
  When R1 = aryl and R2 = hydrogen, the trans:cis ratio is >20:1 in all reported cases.21  However, 
when R3 = alkyl, or R1= Ph and R2 = CH3 the stereochemical outcome is diminished to as low as 
5.9:1 trans:cis.  Lastly, several transformations of the Bpin moiety were detailed in their report; 
one example, shown below, forms chiral aminol 51. 
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Amino halogenation of ACPs in the presence of FeCl3 and TsNCl2 was investigated by 
the Shi group (Scheme 12).22  The iodinated product 55 was formed by including sodium iodide 
in the reaction; this suggests the reaction proceeds through an aziridinium ion, and not through a 
bridged halide cation. 
Scheme 12. Iron-Catalyzed Aminochlorination of ACPs22 
 
Furthermore, Shi et al. also studied the bisacetoxylation of ACPs under Au- and Pd- 
catalyzed conditions to yield ring cleaved products 57/58 (Scheme 13).23,24  This method 
provides the bisfunctionalized products in good yield, although alkyl substituted ACPs fail to 
react selectively. 
Scheme 13. Bisacetoxylation of ACPs Under Pd or Au-Catalyzed Conditions 
 
ACPs have also been utilized to access chiral cyclobutanones by Fukumoto et al. By 
employing Sharpless asymmetric bishydroxylation agent, -AD-mix, to ACP 59 several chiral 
cyclopropane diols 60 were obtained (Scheme 14).25  Conversion of these diols to the cyclic 
sulfates induced rearrangement to give cyclobutanones of structure 61. In this report, only 
cyclobutanone 61a was formed in sufficient enantiomeric excess to demonstrate proof of concept 
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for the synthesis of chiral cyclobutanones from ACPs via this route.  By utilizing 61a, the total 
synthesis of natural products (-)-debromofilformin (62a) and (-)-filiformin (62b) was reported. 
Scheme 14. Enantioselective Bishydoxylation of ACPs/Rearrangement to Cyclobutanones 
 
 Elucidation of the lack of enantiomeric excess in Fukumoto’s reactions with investigated 
by Krief et al. who reported high ee values for a similar synthesis of cyclobutanones (Scheme 
15).26,27  Instead of employing cyclic sulfates, Krief utilizes BF3•Et2O to promote rearrangement 
to the cyclobutanone followed by mCPBA oxidation to chiral lactone 66.  Little loss of ee 
installed in the dihydroxylation process was observed over this three step synthesis.  Thus Krief 
hypothesized the lack of ee observed in Fukamoto’s reactions results from the thionyl chloride 
induced rearrangement.   
Scheme 15. Bishydroxylation of ACPs Toward the Synthesis of Chiral Lactones 
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When Fukumoto’s conditions were repeated by Krief, cyclic sulfonates were obtained 
which decomposed to cyclobutanones with little preservation of chirality.  It should be noted that 
Krief only investigated alkyl substituted ACPs, where Fukumoto typically employed aryl 
substituted ACPs.  This distinction may cause the ACP substrates to react differently in the 
asymmetric dihydroxylation, as well as the rearrangement to the cyclobutanone. Additionally,  
Krief then expedited the synthesis of chiral and racemic cyclobutanones employing various 
oxidizing conditions (Scheme 16).27  
Scheme 16. Direct Conversion of Cyclopropyl Diols and ACPs to Substituted Lactones 
 
Metal-catalyzed diselenation and di-tosylation of ACPs was developed by the Yu group.  This 
methodology was shown to be an effective route to geminally substituted cyclobutanes (Scheme 
17).28  By employing TiCl4 as the catalyst, both aryl and alkyl substituted ACPs were effectively 
reacted to geminally substituted cyclobutanes 72, 73, and 76.  When the authors expanded the 
scope of the reaction to FeCl3 catalyzed conditions, disubstituted ACPs failed to rearrange and 
the ring open product 75 was obtained. 
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Scheme 17. Diselenation and Di-tosylation of ACPs Under Ti- and Fe-Catalyzed Conditions 
 
C-C, C-O bond forming reactions.  Transition metal chemistry provides many options for 
entry into a variety of new carbon-carbon and carbon-oxygen bond formation across ACPs. 
These reactions can be strategically employed to form highly substituted carbocyclic and 
heterocyclic scaffolds.  Yamamoto demonstrated one example of the carboalkoxylation of ACPs 
catalyzed by Yb(OTf)3 to synthesize substituted indene 79 (Scheme 18).
29  This method forms a 
carbon-carbon bond and carbon-oxygen bond across the ACP, followed by electrophilic addition 
of the arene to an oxonium intermediate, resulting in the formation the indene ring. 
Scheme 18. Yb(OTf)3 Catalyzed Carboalkoxylation of ACPs to Substituted Indenes 
 
 Shi demonstrated a Lewis-acid catalyzed Prins-type reaction of alcohol tethered ACPs to 
yield highly substituted tetrahydrofuran products (Scheme 19, Eq. 1).30  The reaction proceeds 
through condensation of the alcohol substituted ACP 80 with aldehydes or N-tosylimines 81 to 
yield oxonium intermediate 84.  Cyclization followed by nucleophilic attack by an alcohol from 
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a second molecule of 80, yielded substituted tetrahydrofurans 82 and 83.  In almost all cases, 
compound 82 was formed in >52% yield. An exception to this is when R1 = H and R2 = Ph, 
reversing the steric effects surrounding the ACP; under these conditions compound 83 is formed 
preferentially and tetrahydrofuran 82 is formed as the minor product. 
Scheme 19. Zinc or Scandium-Catalyzed Prins-Type Reaction of ACPs 
 
Coupling of imine 86 was attempted with ACP 85, but sluggish reactivity was observed.  Best 
results were obtained under indium-catalyzed conditions to yield aniline substituted product 87 
in 19% yield.  It was proposed that aniline, being a poorer leaving group than tosyl-amine or 
water, does not undergo a Prins-type cyclization. Instead, formation of 87 proceeds through 
direct addition of the imine to the ACP followed an intramolecular cyclization of the alcohol 
forming the tetrahydrofuran ring (Eq 2. Scheme 19). 
An interesting tandem carbon-oxygen, carbon-carbon bond formation was also reported 
by the Shi group in an oxycyanation reaction (Scheme 20).31  An intramolecular source of CN- is 
produced from oxidative insertion into the N-CN bond of 88, enhanced by the Lewis acid (BEt3).   
15 
 
 
Scheme 20. Palladium-Catalyzed Oxycyanation of ACPs 
 
Only ACPs were applicable to this transformation; substitution of the cyclopropane moiety for 
cyclobutane or geminal-dimethyl group led to no reaction.  A small amount of compound 90 was 
observed in this reaction. The formation of this product is due to cycloisomerization of the 
starting material, and not the reaction conditions, since it is also formed upon heating of 88 in the 
absence of the other reactants.  
 Furthermore, Shi reported tandem C-C, C-O bond formation under Pd-catalyzed 
condition by the direct addition of carbon dioxide to alkyl substituted ACPs 91 (Scheme 21).32  
In all cases a mixture of two products (92a and 92b) was obtained resulting from the addition of 
CO2 to either face of the ACP.  Substituent effects around the cycloalkyl ring system influenced 
the selectivity.  Unfortunately, aryl substituted ACPs were reluctant to react under these 
conditions. 
Scheme 21. Palladium-Catalyzed Addition of CO2 to ACPs 
 
 C-C, C-N bond formations.  Simultaneous carbon-carbon, carbon-nitrogen bond 
formations across ACPs are much less prevalent in the literature; however, these reactions have 
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high potential to yield biologically relevant heterocycles.  An example of ACP carboamination 
was reported by Cui et al., where benzamides (93) were coupled with ACPs of structure 94 
(Scheme 22).13  A variety of benzamides were investigated, and in all reported cases good yields 
of the resulting tetrahydroisoquinoline 95 was obtained.  When 2-furyl amides were utilized, an 
unanticipated ring opening reaction occurred and led to the formation of substituted azepinone 
compounds. This transformation was also applicable to a variety of substituted 2-furyl amides, 
including a benzofuran substituted amide which reacted to form tricyclic compound 96a.   
Scheme 22. Rhodium-Catalyzed Carboamination of ACPs via sp2 C-H Activation 
 
Mechanistic analysis by Xia et al. detailed DFT calculations suggesting that the above 
reaction likely proceeds through an initial C-C bond formation followed by C-N bond formation 
(Scheme 23).33 
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Scheme 23. Proposed Intermediates in the Rh-Catalyzed Carboamination of ACPs 
 
Most importantly, Xia desired to uncover the reason for the difference in the reaction outcome 
when furyl-amides were employed, versus benzamides.  Intermediate 97 was identified as the 
point of divergence in the mechanism, where -carbon elimination leads to azepinone 96 or C-N 
bond formation leads to isoquinoline 95.  It was found that with benzamides, steric constrains 
from the 1,2-phenylene group disfavor -carbon elimination, which promotes C-N bond 
formation through Rh(V) complex 97a.  However, when 2-furyl amides were utilized, -carbon 
elimination is more favorable than C-N bond formation for intermediate 97b. This results in the 
formation of complex 99, which then undergoes a C-N bond forming process to yield azepinone 
96.   
C-C, C-C bond formations (including perfluoroalkylations).  Reports of the metal-
catalyzed construction of two new carbon-carbon bonds across an ACP are uncommon in the 
literature.  In general these reactions have been utilized to produce highly functionalized 
intermediates, or strategically employed to produce polycyclic scaffolds.  A bisalkylative method 
involving ring cleavage of meso-ACPs 101 was developed by Ogata et al. (Scheme 24).34  This 
was accomplished by nickel-catalysis in the presence -unsaturated carbonyls 100 and 
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triethylborane, and the ring cleaved products (102) were obtained in good yields with a wide 
variety of ketones.  Even when a monosubstituted ACP was employed, good regioselectivity in 
the reaction was observed and the bis-alkylated product was isolated in 56% yield. 
Scheme 24. Nickel-Catalyzed Bisalklation of ACPs 
 
An approach to the desymmiterization of meso-ACPs in an enantiospecific fashion was 
shown by Ukaji et to give biscarbonylated products 105 (Scheme 25).35  Enantioinduction in 
these reactions was derived from the metal-ligand complex; however, only moderate enantio-
control was observed, even in the best cases.  Compound 105 was still formed in the absence of 
ligand; however byproduct 106 was observed when a ligand was not utilized. 
Scheme 25. Palladium and Copper-Catalyzed Biscarbonylation of ACPs 
 
Reactions forming carbon-carbon bonds between ACPs with perfluoroalkanes have been 
recently reported by Shi et al.36  Incorporation of fluorine atoms into the backbone of carbon 
scaffolds has great importance in medicinal chemistry and material sciences.37  Pairing the 
addition of perfluoroalkyl groups with the addition of another moiety across an ACP can be a 
powerful technique to access complex fluoroalkylated structures.  Shi employs this technique to 
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access a variety of trifluoromethylated dihydronaphthalenes 109, under Cu-catalyzed conditions 
(Scheme 26). 
Scheme 26. Copper-Catalyzed Radical Trifluormethylation/Cyclization of Aryl ACPs 
 
This reaction is proposed to proceed via the formation of .CF3, since radical traps such as 
TEMPO and BHT decreased yield and/or halted product formation.  Additionally, this radical 
transformation was strategically applied to substituted ACPs of structure 110 (Scheme 27).38  
Employing an iron-catalyst was found to be advantageous for the transformation of most 
substrates.  Gratifyingly, the wide scope of this transformation yielded a variety of highly 
substituted azepanes 112 with good yields in the majority of cases. 
Scheme 27. Metal-Catalyzed Trifluoromethylation of Acrylamide Teathered ACPs 
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Interestingly, spirocycle fused azapane 111 was formed under Fe-catalyzed conditions when R1 
of 110 is substituted with a methoxy group.  Furthermore, under Pd-catalyzed conditions, the 
authors demonstrate the addition of difluoromethylene groups and perfluoroalkyl groups to 
allylamine tethered ACPs 113. These reactions commence via a carbon-carbon bond forming 
radical cascade, ending in Pd-catalyzed carbon-iodine bond formation to yield functionalized 
azapane 115. 
Conclusion: 
While the bisfunctionalization of ACPs has been moderately explored over the past few 
decades, synthetic chemists have yet to embrace and utilize the full potential of these substrates.  
Through the application of traditional olefin methodology, ACPs are capable of yielding highly 
substituted heterocycles and synthetic intermediates from relatively simple starting materials.  
The following chapters will detail further investigations into the bisfunctionalization of ACPs. 
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CHAPTER TWO 
PALLADIUM-CATALYZED CARBOAMINATION OF ALKYLIDENECYCLOPROPANES: 
SYNTHESIS OF CONGESTED PYRROLIDINES AND PIPERIDINES 
Introduction
The bisfunctionalization of unsaturated compounds is a powerful strategy employed to 
increase molecular complexity in a single synthetic operation. Incorporating an intramolecular 
heteroatom nucleophile as part of the bisfunctionalization provides an effective route for 
complex heterocycle synthesis. Nitrogen- containing heterocycles are a constant target in new 
method development because of their importance in pharmaceutical development.39,40  Saturated 
N-heterocycles are particularly critical to access through new method development. 41–43  
Moreover, although routes are available to create these N-heterocycles, the synthesis of densely 
functionalized heterocycles is challenging.41–43  We sought to explore a bisfunctionalization 
strategy to generate congested N-heterocycles using a carboamination reaction. The laboratories 
of Wolfe44–50 and Michael51,52 have pioneered the carboamination of olefins to create a variety of 
N-containing heterocycles. For example, Wolfe has demonstrated the efficient synthesis of 
pyrrolidines (117) through a palladium-catalyzed carboamination of amine-appended olefins in 
the presence of aryl bromides (Scheme 28, Eq. 1).  Although this elegant strategy has been 
employed in the synthesis of a range of N-heterocycles, extension of this method to incorporate 
substitution at the R-position is uniquely challenging.53  A recent advance by Wolfe 
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demonstrated the ability to generate chiral tetrahydroindoloisoquinoline structures starting from 
alkenyl aniline derivatives.54 
Scheme 28. Carboamination Routes for N-Heterocycle Syntheses 
 
Despite this advance, translation to pyrrolidine or piperidine systems is not as efficient. While 
exploring methods to circumvent this current problem, we were inspired by a seminal report by 
Fournet and co-workers, which showed one example of a successful carboamination of an 
amine-appended alkylidenecyclopropanes (ACPs) to generate pyrrolidine 119 (Eq. 2).10  This 
approach showed that the synthetic versatility of the cyclopropyl group under palladium catalysis 
provides a functional handle on the pyrrolidine product for further product elaboration (Eq. 3). 
We were excited to explore this unique reactivity and expand on the synthetic utility of 
employing ACPs in bisfunctionalization processes.  Herein, we report the carboamination of 
alkylidenecyclopropanes for the synthesis of congested pyrrolidines (121) and piperidines (122). 
Results and Discussion 
Initially, accessing ACP 126 was intended to be achieved via the same route employed by 
Fournet et al. (Scheme 29, Eq. 1); however, acid catalyzed cracking of 2,3-dihydropyran 
produced an impurity (125) which was inseparable by silica gel chromatography.  Furthermore, 
an attempt to access ACP 126 was also made from 1,4-butanediol 127, yet ketone 129 was prone 
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to hydrate formation and water solubility of the product greatly diminished the yield of the ACP 
precursor (Eq. 2). 
Scheme 29. Initial Attempts to Access ACP 126 
 
While accessing ACP 126 proved to be non-trivial, it also limits the ability of the synthetic 
chemist to induce variability in these starting ACPs.  By utilizing routes 1 and 2 in the scheme 
above, the resulting ACP’s substitution is limited to a hydrogen atom (Eq. 3); instead, accessing 
disubstituted ACP 120 would allow for the introduction of further complexity into the final 
product (Eq. 4). 
ACP 120 was conveniently synthesized starting from 2-pyrrolidinone 130.  Initial Boc-
protection of 2-pyrrolidinone,55 followed by a ring opening Grignard reaction56 efficiently 
granted access to -amino ketones 135a-135e (Table 1).  Primary, secondary, aryl and vinyl 
Grignard reagents all reacted successfully to form a variety of substituted ketones.  Wittig 
olefination to form the ACP was only successful in producing linear alkyl substituted ACPs 
(entries 1 – 3) and aryl substituted ACP (entry 7).57 
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Table 1. Synthesis of Boc-Protected -Aminoketones and ACPs 
 
[a] Reactions were conducted under N2 with dropwise addition of the Grignard reagent (1.2 equiv.) to a 0.5 M 
solution of the pyrrolidine and TMEDA (1.2 equiv.) in THF in at -78 °C for 1 hour.  [b] Yields reported are isolated 
yields.  [c] Reactions were conducted under argon where a suspension of cyclopropylphosphonium bromide (1.3 
equiv.), sodium hydride (1.4 equiv.), and TDA-1 (Tris[2-(2-methoxyethoxy)ethyl]amine) (10 mol% with respect to 
base) was stirred for 6 hours at 62 °C followed by addition of the ketone and an additional hour of stirring at 62 °C.   
We began our investigation by screening reaction conditions that would allow for the 
intramolecular carboamination of 136a.  We observed that the carboamination was achieved 
under a variety of palladium-catalyzed conditions.  Interestingly, a replication of the Fournet 
group’s carboamination conditions,10 with amine bases and aryl iodides, yielded no reaction. 
Additionally, aryl iodides reacted less selectively, and aryl chlorides gave poor conversion.  No 
conversion was observed in the absence of palladium, ligand, aryl halide, or base. An initial 
reaction screen indicated that employing cesium carbonate as the base in dioxane solvent 
provided the highest conversion of ACP 136a to the pyrrolidine product 137a (Table 2).   
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Table 2. Optimization of the Palladium-Catalyzed Carboamination of ACPs 
 
Entry[a] ligand 137a (%)[b] 138a (%)[b] 139a (%)[b] 
1 PPh3 25 < 5 50 
2 BINAP 50 < 5 33 
3 XantPhos 30 30 30 
4 dppf 60 8 15 
5 DPEPhos 10 < 5 30 
6 P(o-tol)3 25 < 5 75 
7 XPhos 80 10 10 
[a] Reactions were conducted under argon with Pd2dba3 (2.5 mol %), ligand (5 mol%), Cs2CO3 (2.2 equiv.), and 
PhBr (2.2 equiv.) at 0.4 mM in dioxane at 100 °C.  [b] Percentage calculated using uncalibrated GC analysis of the 
crude reaction mixture after 14 hours.  
 
Importantly, we observed that consumption of 136a gave rise to the formation of three main 
products, which were identified as the desired pyrrolidine 137a, N-aryl ACP 138, and diene 139a 
as a mixture of olefin isomers. We then screened a variety of phosphine ligands in order to 
mitigate the formation of byproducts 138 and 139.  This screen showed that catalyst system 
Pd0/XPhos selectively formed pyrrolidine 136a while minimizing side product formation (entry 
7). We then investigated the scope of the carboamination using the optimized conditions (Table 
3). Using amino-ACP 136a, a variety of electron-donating and electron-withdrawing aryl halides 
afforded pyrrolidines 137a–137g in good to excellent yields.   
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Table 3. Scope of the Congested Pyrrolidine Synthesis 
 
[a] Reactions were conducted under argon with Pd2(dba)3 (2.5 mol%), XPhos (5 mol%), Cs2CO3 (2.2 equiv.), and 
ArBr (2.0 equiv.) at 0.4 mM in dioxane at 100 °C. [b] Reported yields are the average NMR yields (referencing to an 
internal standard of 1,3,5-trimethoxybenzene (10 mol%), which was added prior to aqueous workup) of two 
reactions based on integration of 1H NMR analysis of the crude reaction mixture after 14 h. 
These results show that the aryl bromide component has minimal effect on the course of 
the reaction. Exceptions include 4-nitrobromobenzene and 4-bromobenzonitrile, which did not 
provide the respective pyrrolidine products in appreciable quantities.  This observation is likely 
due to the increased rate of reductive elimination from the Pd(aryl)(amido) complex, or ligation 
of the electron-withdrawing group to palladium. We then analyzed modification of the R-group 
of the ACP. Alkyl substitution was well-tolerated and provided pyrrolidines 137h–137k in good 
yields. Unfortunately, the phenyl substituted ACP 136g did not react to produce 137l. The 1-
position of an ACP is more electron rich in 1-alkyl-1-aryl ACPs when compared to their 1,1-
dialkyl substituted analogs, thus the phenyl-substituted ACP 136g may be less susceptible 
toward nucleophilic additions.  Additionally, deprotection of 136a to the free amine also 
afforded no reaction when subjected to the carboamination procedure (not shown). Finally, 
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transesterification of the Boc group of 136a with Ti(OiPr)4 provided an isopropyl substituted 
carbamate, which was also surveyed in the carboamination conditions, producing products 
137m–137o in excellent yields. These isopropyl substituted pyrrolidines provide access to a 
more robust protecting group on the pyrrolidine product, opposed to the acid labile Boc group. 
The complex splitting patterns in the 1H NMR, arising from Boc-amide rotamers, led us 
to deprotect and crystallize the pyrrolidine product to verify structural assignment. Pyrrolidine 
137a was effectively deprotected to 138a in 56% yield using a biphasic mixture of 12 M 
HCl/toluene at 70 °C; however, we were unable to obtain crystals of X-ray quality (Scheme 30).  
Scheme 30. Boc Deprotection and Crystallization of Pyrrolidines 137a & 137b 
 
Applying this deprotection method to pyrrolidine 137b and recrystallizing from Et2O with 4-
nitrophenylacetic acid provided crystalline compound 140, which provided X-ray confirmation 
of the pyrrolidine structure. 
The carboamination of ACP 136 urges interesting mechanistic considerations based on 
the observed byproducts.  The Wolfe group has reported a number of sophisticated mechanistic 
interpretations of the carboamination of olefins.58  These reports indicate that the reactions of 
mono- and di-substituted alkenes likely proceed through a C-N bond forming syn-
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aminopalladation process and conclude with C-C bond forming reductive elimination.  Based on 
these precedents, it is plausible that the mechanism in Scheme 31 may be operative. 
Scheme 31. Proposed Mechanism for the Carboamination of ACP 136. 
 
This mechanism would commence with the oxidative insertion of a Pd0Ln complex to 
form PdII(aryl)(Br) complex A. Then, displacement of the bromide by the nitrogen of the Boc-
protected amide generates the Pd(aryl)(amido) complex B. From intermediate B, we can 
presumably achieve the formation of each observed reaction product.  Aminopalladation to form 
complex C followed by reductive elimination produces pyrrolidine product 137, which follows 
the mechanistic studies conducted by Wolfe. 
Alternatively, intermediate B may undergo reductive elimination of the aryl group to 
produce N-aryl product 138. Finally, intermediate B can proceed through a carbopalladation to 
give intermediate D. This intermediate can also provide pyrrolidine product 138 through a 
reductive elimination, or undergo a -carbon elimination to give intermediate E, and subsequent 
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-hydrogen elimination would produce observed diene 139.  Rationalizing the diene formation 
through an exclusive aminopalladation mechanism is nontrivial; therefore, we expect that a 
carbopalladation mechanism is also operative under our conditions. 
With access to these highly substituted pyrrolidine products, focus was then directed at 
probing the utility of the cyclopropane ring as a functional handle.  The reactivity of 
cyclopropanes is well reported in the literature, yet the majority of these transformations require 
polarized, donor-acceptor cyclopropanes, to enhance the cyclopropane’s reactivity.59–61  
However, unactivated cyclopropanes are still susceptible to several transformations, such as 
hydrogenation, oxymercuration, cycloadditions, and cleavages mediated by frustrated Lewis 
pairs (Scheme 32).62–69 
Scheme 32. Attempted Cyclopropane Functionalizations of Pyrrolidine 137a 
 
Oxymercuration of 137a (Scheme 32, Eq 1) yielded a Boc-cleaved product; no evidence of 
cyclopropane cleavage product 150 was observed by GC-MS or 1H or 13C NMR.  Cycloadditions 
of 137a with NaNO2 (Eq. 2) or tetracyanoethylene (not shown) were also unsuccessful on our 
cyclopropane substrate.  Frustrated Lewis pairs (Eq. 3) did react with pyrrolidine 137a to yield 
an unidentified white powder; 1H, 13C, and 31P NMR were inconclusive in definitively 
identifying the product’s structure.  The NMR experiments suggest the structure of this product 
is a mixture of isomers structurally related to compound 153, yet this could not be discerned 
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definitively, nor could X-ray quality crystals of the product be obtained.  Lastly, various 
hydrogenation techniques (Eq. 4) failed to yield either of the expected products, 154 or155.   
While none of these reactions were successful, it was hypothesized that the structural 
density surrounding the cyclopropane ring may be hindering access to the required chemical 
space for reactivity. To circumvent this two options were proposed: accessing the cyclopropane 
electronically via a quinone methide type intermediate (Scheme 33, Eq 1), or removing the Boc-
group to ease the steric hindrance surrounding the cyclopropane ring and potentially utilize the 
pyrrolidine nitrogen as a directing group for further transformations (Eq 2).70,71 
Scheme 33. Attempted Cyclopropane Ring Cleavage and C-H Functionalization 
 
Since accessing a quinone methide type intermediate would severely limit the scope of 
this cyclopropane functionalization to pyrrolidine 156, the deprotection followed by 
cyclopropane functionalization route was pursued.  While HCl/Toluene at 70 °C was previously 
used to form deprotected pyrrolidines 137a and 138b, when repeated on a larger scale some 
decomposition was observed, and alternative deprotection method was demanded.  Interestingly, 
subjecting the Boc-protected pyrrolidines to the deprotection conditions of trifluoroacetic acid 
(TFA) in DCM at 0 °C provided an unexpected rearrangement product 160, which was 
confirmed by X-ray diffraction (Scheme 34). 
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Scheme 34. HCl/Toluene Deprotection vs Trifluoroacetic Acid Deprotection 
 
Due to the fact that the piperidine was produced in excellent yield from the corresponding 
pyrrolidine, we decided to streamline the synthesis of congested bicyclic piperidines through a 
two-step protocol with no intermediate isolation. We first attempted to add TFA directly to the 
reaction mixture upon completion of the carboamination; however, this process did not result in 
rearrangement of the pyrrolidines. We were pleased to find that the crude reaction mixture could 
be filtered through celite and then subjected to TFA in DCM at 0 °C to afford the rearranged 
piperidine products 161 after basic workup. Using this two-step carboamination/rearrangement 
process we explored the scope of the piperidine synthesis (Table 4).  
Table 4. Scope of the 2-Step Congested Piperidine Synthesis. 
 
[a] Reported isolated yields are an average of two 0.4 mmol reactions. Relative stereochemistry is depicted. [b] 
Reactions were conducted under argon with Pd2(dba)3 (2.5 mol%), XPhos (5 mol %), Cs2CO3 (2.2 equiv.), and ArBr 
(2.0 equiv.) at 0.4 mM in dioxane at 100 °C. [c] Boc-deprotected pyrrolidine was obtained under these conditions. 
[d] Yield reported from the pyrrolidine intermediate. 
The tandem reaction proceeded nicely on the Boc-protected starting materials to provide 
products 161a–161f. The rearrangement was ineffective when employing aryl bromides 
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containing electron-withdrawing groups. Therefore, we were unable to obtain piperidine 161g, 
but instead achieved clean conversion to the deprotected pyrrolidine 138b. This result suggests 
that a carbocation intermediate is operative and requires electron donating arene stabilization. 
Finally, we were able to achieve the carboamination/rearrangement on the isopropyl–carbamate 
substrate to yield piperidine 161h with the protecting group still intact. Interestingly, the 
rearrangement appears to occur very rapidly, since, when pyrrolidine 138a was subjected to the 
TFA conditions, no reaction occurred. Based on these results, we expect that the rearrangement 
occurs prior to cleavage of the Boc group and propose the mechanism in Scheme 35. 
Scheme 35. Mechanism for the Rearrangement of Pyrrolidines to 2-Azabicyclooctanes 
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This mechanism would commence with protonation of the carbamate, followed by leaving of the 
nitrogen forming tertiary carbocation 163.  The cyclobutane ring is formed through an alkyl shift 
to yield intermediate 164 and subsequent ring closure and deprotection produce the bicyclic 
compound 161a. Analyzing this mechanism raises the question: is the rearrangement of 
pyrrolidine 138b slow relative to Boc-cleavage, rendering the compound unreactive, or is the 
1,2-alkyl shift of intermediate 163g unfavorable with electron poor arenes (Scheme 36)?  To 
determine this, pyrrolidine 137n was submitted to the rearrangement conditions and no product 
formation was observed, implying the rearrangement of 163g is unfavorable under the tested 
conditions. 
Scheme 36. Attempted Rearrangement of 3-NO2-pyrrolidine 137n 
 
Conclusion 
In summary, we report the efficient synthesis of highly congested pyrrolidines and 
piperidines through the intramolecular carboamination of alkylidenecyclopropanes. This method 
is capable of creating a functional handle (cyclopropyl group) adjacent to the pyrrolidine ring, 
which can be utilized for subsequent reactions. We have streamlined the synthesis of the 
piperidine products using a two-step process that does not require isolation or purification of the 
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pyrrolidine intermediate. We are now working on developing an asymmetric variant of these 
reactions for the enantioselective synthesis of chiral pyrrolidines and piperidines. These unique 
scaffolds are also currently being tested for their biological activity, which will be reported in 
due course. 
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CHAPTER THREE  
ALKYLIDENECYCLOPROPANES AS PRECURSORS TO SUBSITUTED INDOLIZINES 
Introduction
The synthesis of N-heterocyclic scaffolds is integral to medicinal chemistry, thus new 
methods to access these structures are always of interest.  In recent years, considerable attention 
has been given to the synthesis of the indolizine ring system due to their interesting biological 
properties, such as anticancer, anti-fungal, and anti-hypertensive activities (Figure 1).72–75 
Figure 1. Indolizine Numbering and Biologically Active Indolizines72–75 
 
While many routes to indolizines have been explored in recent years, most methods require the 
1, 2, or 3-position to be substituted by an electron withdrawing group (Scheme 37).76–86 
Scheme 37. Examples of Common Indolizine Formations. 
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Furthermore, there are few examples leave the reactive 3-position of the indolizine unsubstituted.  
The 5-membered ring of indolizines has been identified as the site of highest electron density in 
the indolizine ring system87, and can easily be manipulated to install further functionalities onto 
the indolizine scaffold.88 
While many of these indolizine formations are cycloisomerizations or 
cyclocondensations with various  containing units, ACPs have not been thoroughly investigated 
as indolizine precursors.  A unique result from the Yamamoto lab detailed the synthesis of 1,2-
dimtheylindolizine 180 under Pd-catalyzed conditions from a pyridine tethered ACP 176 
(Scheme 38).89  Interestingly, the proton source could not be identified, as the addition of no H+ 
source was found to be beneficial to the reaction.   
Scheme 38. Yamamoto’s Indolizine Synthesis and Proposed Carboamination Product89 
 
It was proposed that the indolizine product could be further functionalized by incorporating a 
base and a coupling partner, such as an aryl bromide.   
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Results and Discussion 
Investigations began with the synthesis of pyridyl ACPs of structure 181 which was 
achieved through the Wittig reaction of 2-pyridyl ketones 183.  Following typical procedures for 
ACP forming Wittig olefinations, extended reaction times were required to fully convert the 
starting material.57,90  NMR analysis of the reaction indicated the buildup of stable intermediate 
185 during the course of the reaction, as described by Subramanyam (Scheme 39).91 
Scheme 39. Wittig Reaction of 2-Pyridyl Ketones 
 
Preforming the Wittig olefination at 100 °C in toluene overcame the metal chelating ability of 
185 and provided complete conversion to the ACP in 1 hour, when KOtBu was utilized as the 
base.  A variety of ACPs were accessed via this route (Table 5). 
Table 5. ACP Synthesis via Wittig Reaction of 2-Pyridyl Ketones 
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Since ACP 188a was employed by Yamamoto, it was selected to be screened in a variety 
of Pd-catalyzed carboamination conditions (Table 6).   
Table 6. Optimization of Indolizine Synthesis via ACP Carboamination 
 
[a] Reactions were conducted under argon with Pd source , ligand, base, and ArBr, at 0.8 mM in PhMe at 110 °C. [b] 
Percentage calculated using uncalibrated GC analysis of the crude reaction mixture after 14 hours referencing to an 
internal standard of 1,3,5-trimethoxybenzene which was added prior to aqueous workup (10 mol%). [c] Yield of the 
major product, 191.  [d] Yield of the major product 192a. [e] Yield of the major product, 190.   
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It was quickly identified that catalyst mixtures of Pd(OAc)2 and sterically hindered 
monodentate ligands were most efficient for this carboamination process.  Remarkably, when 
PhDavePhos was utilized as the ligand, indane product 190 was the major product; furthermore, 
a bidentate ligand, XantPhos selectively produced 3-Phenyl indolizine 192a.  Since the 
Pd(OAc)2/P(o-tolyl)3 catalyst system appeared to perform the best, it was hypothesized that the 
Herrmann-Beller palladacycle was active catalyst.92  Synthesis of the palladacycle and 
employing it in the indolizine formation lead to comparable reactivity.  A screen of bases 
indicated that CsF was a superior base compared to Cs2CO3; and stronger bases such as 
NaHMDS lead to decomposition of the starting material and/or product.  Insufficient base in the 
reaction lead to the formation of 1,2-dimethylindolizine 191. 
With the optimized conditions in hand, screening of several aryl halides indicated the 
reaction was tolerant of both electron poor and electron rich aryl halides.  Additionally, when the 
pyridine ring was substituted with electron donating groups, fair to moderate yields were 
observed (Table 7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
40 
 
 
Table 7. Substituted Indolizines via Palladium-Catalyzed Carboamination of ACPs 
 
[a] Reactions were conducted under argon with Herrmann-Beller palladacycle (5 mol %), CsF (4 eq), and PhBr (2.2 
eq) at 0.8 mM in toluene at 110 °C.  [b] Percentage calculated using NMR analysis of the crude reaction mixture 
after 14 hours heating referencing an internal standard of 1,3,5-trimethoxybenzene (10 mol%) which was added 
before aqueous workup.  
Unfortunately, when isopropyl substituted ACP 188c was employed <2% of indolizine 193 was 
formed and indane product 194 was observed as the major product (Scheme 40).  Phenyl 
substituted ACP 188f was also tested, and indolizine 195 was formed in low yield (23%) due to 
the poor the selectivity of the reaction. 
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Scheme 40. Product Ratios for ACPs 188c and 188f 
 
The underlying mechanism governing this transformation is unclear, yet the reactions 
detailed in Scheme 41 provide information as to how the reaction may proceed. 
Scheme 41. Mechanistic Investigations 
 
Incorporating oxidants and aryl iodides in the reaction mixture did not enhance product 
formation, indicating a Pd0/PdII rather than a PdII/PdIV may be operating.  In the absence of base, 
the formation of 1,2-dimethyl indolizine 191 was observed.  Interestingly, in the absence of the 
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aryl bromide, no reaction was observed, implying the aryl bromide is still required for 1,2-
dimethylindolizine formation, even though it is not incorporated into the final product.  With this 
information, the bimetallic mechanism in Scheme 42 is proposed.   
Scheme 42. Proposed Mechanism for the Formation of 2-Benzyl Indolizine 189a 
 
The reaction begins with generation of the Pd0 catalyst followed by oxidative addition to 
both the distal carbon-carbon bond of ACP 188a to form PdII-complex 199, and to the aryl 
bromide to form complex 198.  A transmetalation between these two palladium species would 
lead to bispalladated compound 200.  The indolizine ring system is created by C-N bond forming 
reductive elimination of one of the palladium complexes forming salt 201.  
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Deprotonation/aromatization of 201 forms intermediate 202, and subsequent C-C bond forming 
reductive elimination produces 2-benzyl indolizine 189a.  While there are limited reports of 
palladium-palladium transmetalation reactions,93,94 this mechanism is supported by the 
previously described observations.  If insufficient base is available, intramolecular 
protodemetalation of the alkyl-PdII-aryl complex would lead to dimethyl indolizine 191.  The 
requirement of the aryl halide being present for indolizine is less clear, but may be related to the 
formation of pyridinium salt intermediate 201.  Accessing intermediate 201 could also be 
achieved via a PdII/PdIV mechanism; however, there is no evidence to support this pathway is 
operating. 
Attention was then turned to the synthesis of 3-phenyl indolizine 192, which was formed 
when a Pd(OAc)2/XantPhos catalyst system was employed (Scheme 43).  GC-analysis of the 
reaction mixture after 1 hour indicated that the majority of the ACP had been consumed and 1,2-
dimethylindolizine was formed, as well as a minor amount of 3-phenyl-1,2-dimethylindolizine.  
Over the course of the next 7 hours, the amount of 1,2-dimethylindolizine decreased 
proportionally with respect to an increase in 3-phenyl product. 
Scheme 43. Proposed Route of Formation for 3-Aryl Indolizines 192 
 
This reactivity is consistent with an electrophilic aromatic substitution reaction of 
indolizines described by Gevorgyan and coworkers, which occurs selectively at the 3-position.87  
To test if the formation of indolizine 192 is occurring through an EAS mechanism, a competition 
44 
 
 
experiment was performed in which 3 aryl halides were included in the reaction mixture 
(Scheme 44). 
Scheme 44. Aryl Halide Competition Experiment for 3-Aryl Indolizine Formation 
 
Selective formation of indolizine 192b was observed, supporting an EAS mechanism.  
Expansion of this reaction to other pyridyl ACPs, as well as scale up of this reaction has not 
yielded fruitful results. 
Conclusion 
Pyridine tethered ACPs have been successfully utilized as indolizine precursors, granting 
access to an array of substituted electron rich indolizines.  The reaction is applicable to couplings 
with both electron rich and electron poor arenes.  These indolizines can be utilized as valuable 
synthetic intermediates, as the 3-position is left unsubstituted for additional functionalizations.  
Further investigations into the mechanism of this reaction, enhancement of the substrate scope, 
and one pot formation of 3-aryl indolizines from pyridyl ACPs are underway.  
 
 45 
APPENDIX A 
EXPERIMENTAL INFORMATION 
FOR CHAPTER TWO 
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Unless otherwise noted all reactions were carried out in flame dried or oven dried glassware, 
under an atmosphere of Ar or N2.  All solvents and aryl halides were distilled from CaH2.  
TMEDA was distilled from sodium. Sodium hydride was purchased as a 60% suspension in 
mineral oil and washed with hexanes prior to use.  Pd2dba3 was synthesized from PdCl2 via the 
reported literature method followed by recrystallization from dry chloroform (distilled over 
P2O5.).
 1H NMRs were obtained on either a Varian Inova 500 MHz NMR or a Varian Inova 300 
MHz NMR (specified below for each compound), and referenced to an internal standard of TMS 
(= 0.0 ppm).  13C NMRs were obtained from the previously mentioned instruments at either 
126 MHz or 75 MHz respectively and referenced to residual CHCl3 (= 77.0 ppm).  IRs were 
collected on a Thermo-Nicolet Nexus 470 FT-IR or a Shimadzu IRAffinity-1S FT-IR and 
reported in cm-1.   NMR yields were obtained by comparing the product to an internal standard of 
1,3,5-trimethoxybenzene, which was added to the crude reaction mixture prior to workup.   
HRMS data was obtained using a Shimadzu LCMS IT-TOF mass spectrometer or a Bruker 
MicrOTOF-Q II LCMS. 
 
Representative Procedure for the Synthesis of ACPs 
 
tert-butyl (4-cyclopropylidenehexyl)carbamate (136a): ACP 136a was prepared using known 
ketone 135a.2 In a 3-neck round bottom, a mixture of sodium hydride (0.546 g, 22.8 mmol) and 
cyclopropyltriphenylphosphonium bromide (8.10 g, 21.1 mmol) was suspended in THF (70 mL) 
was prepared in a glovebox of argon atmosphere.  The flask was sealed and removed from the 
glovebox and placed under N2.  TDA-1 (0.520 mL, 1.63 mmol) was added to the suspension, and 
the mixture was stirred and heated to 62 °C for 6 h.  The suspension gradually turned orange.  In 
a separate RBF the ketone (3.5 g, 16.26 mmol) was dissolved in dry THF (14 mL) and added to 
the stirred orange suspension via cannula. The resulting tan mixture was stirred for one h.  After 
one h the reaction was cooled and poured into 200 mL of hexanes and filtered.  The filtrate was 
concentrated and the resulting residue was dissolved in a minimum of dichloromethane and 
loaded onto a silica gel column eluted with EtOAc:Hexanes (5:95).  Pure fractions were 
combined and concentrated to yield alkylidenecyclopropane 136a as a clear colorless to faintly 
yellow liquid (1.91 g, 49%) 1H NMR (CDCl3, 500 MHz):  4.59 (br. s., 1 H), 3.10 (q, J=6.0 Hz, 
2 H), 2.14 - 2.20 (m, 4 H), 1.68 (quin, J=7.3 Hz, 2 H), 1.44 (s, 9 H), 1.00 - 1.08 (m, 5 H), 0.93 - 
0.98 ppm (m, 2 H); 13C NMR (CDCl3, 126 MHz):  155.9, 128.5, 114.6, 78.9, 40.5, 32.1, 28.4, 
27.9, 27.9, 12.4, 1.9, 1.3 ppm   IR (Neat, cm-1): 3351, 2973, 1688, 1514, 1453, 1391, 1269, 
1249, 1168, 1039, 999, 866, 781; HRMS (ESI): calcd for C14H25NO2 [M + H]
+: 240.1919; 
found 240.1906. 
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tert-butyl (4-cyclopropylidenedecyl)carbamate (136c): ACP 136c was synthesized using 
known ketone 136c.3  Prepared analogously to ACP (136a).  The crude residue was dissolved in 
a minimum of dichloromethane and loaded onto a silica gel column eluted with EtOAc:Hexanes 
(5:95).  Pure fractions were combined and concentrated to yield alkylidenecyclopropane 136c as 
a clear colorless to faintly yellow liquid (1.365 g, 25% yield) 1H NMR (CDCl3, 500 MHz):  = 
4.52 (br. s., 1 H), 3.10 (q, J=6.8 Hz, 2 H), 2.11 - 2.19 (m, 4 H), 1.68 (quin, J=7.3 Hz, 2 H), 1.42 - 
1.49 (m, 11 H), 1.23 - 1.33 (m, 6 H), 0.99 (s, 4 H), 0.88 ppm (t, J=6.8 Hz, 3 H); 13C NMR 
(CDCl3, 126 MHz):  = 156.2, 127.5, 115.5, 79.2, 40.8, 35.1, 32.3, 32.0, 29.5, 28.7, 28.2, 27.9, 
22.9, 14.3, 2.2, 2.2 ppm; IR (thin film in DCM, cm-1): 3449, 3366, 3051, 2976, 2957, 2930, 
2870, 2857, 1709, 1506, 1454, 1422, 1393, 1366, 1342, 1263, 1171, 1067, 1042, 991, 908, 895, 
866, 704, 509, 492, 482, 474, 463, 459 ,447, 444, 436, 432, 415, 405   HRMS (ESI): Calcd. for 
C18H33NO2 [M + H]
+: 296.2584; found 296.2586. 
 
tert-butyl (4-cyclopropylidenepentyl)carbamate (136b): ACP 136b was synthesized using 
known ketone 135b.4  Prepared analogously to ACP (136a).  The crude residue was dissolved in 
a minimum of dichloromethane and loaded onto a silica gel column eluted with EtOAc:Hexanes 
(5:95).  Pure fractions were combined and concentrated to yield alkylidenecyclopropane 136b as 
a clear colorless to faintly yellow liquid (1.203 g, 50% yield) 1H NMR (CDCl3, 500 MHz):  = 
4.52 (br. s., 3 H), 3.14 - 3.03 (m, 8 H), 2.18 (t, J = 7.6 Hz, 8 H), 1.80 (t, J = 1.7 Hz, 12 H), 1.69 
(quin, J = 7.4 Hz, 8 H), 1.44 (s, 37 H), 1.05 - 1.01 (m, 8 H), 0.98 - 0.83 (m, 2 H); 13C NMR 
(CDCl3, 126 MHz):  = 155.9, 123.2, 115.8, 78.9, 40.4, 33.7, 28.4, 27.7, 20.5, 2.8, 1.5;  IR (thin 
film in DCM, cm-1): 3449, 3055, 2932, 2978, 1707, 1504, 1422, 1366, 1261, 1165, 895, 706  
HRMS (ESI): Calcd. for C13H23NO2 [M + H]
+: 226.1807; found 226.1806. 
 
Representative Procedure for the Synthesis of  iPr-Carbamate 
 
Isopropyl (4-cyclopropylidenehexyl)carbamate (136g): ACP 136a (0.100 g, 0.418 mmol) was 
dissolved in toluene (2.5 mL) and Ti(OiPr)4 (210 L, 8.44 mmol) was added to the resulting 
solution.  The reaction was stirred at 110 °C for 14 h.  The reaction was cooled to ambient 
temperature and methanol was added to the solution.  A white ppt. formed, which was removed 
by filtration, and the filtrate was concentrated to a yellow oil (0.080 g, 85% yield) 1H NMR 
(CDCl3, 300 MHz):  = 4.90 (spt, J=12.5 Hz, 1 H), 4.57 (br. s., 1 H), 3.14 (q, J=6.2 Hz, 2 H), 
2.10 - 2.25 (m, 4 H), 1.70 (quin, J=7.3 Hz, 2 H), 1.22 (d, J=6.3 Hz, 6 H), 0.91 - 1.09 ppm (m, 7 
H); 13C NMR (CDCl3, 126 MHz):  = 156.3, 128.5, 114.7, 68.1, 40.8, 32.1, 28.0, 22.2, 12.5, 
2.0, 1.4 ppm; IR (thin film in DCM, cm-1): 3447, 3053, 2980, 2936, 1711, 1512, 1422, 1265, 
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1113, 895, 731, 706, 447, 444, 428 HRMS (ESI): Calcd. for C13H23NO2 [M + H]
+: 226.1807; 
found 226.1804.   
Representative procedure for the carboamination of ACPs: 
 
tert-butyl 2-ethyl-2-(1-phenylcyclopropyl)pyrrolidine-1-carboxylate (137a): A mixture of 
Pd2dba3 (9.6 mg, 0.010 mmol 2.5 mol%), XPhos (10 mg, 0.021 mmol, 5 mol%), Cs2CO3 (300 
mg, 0.919 mmol, 2.2 equiv), and bromobenzene (0.088 mL, 0.84 mmol, 2.0 equiv) was prepared 
in a vial to which a solution of ACP 135a (100 mg, 0.418 mmol, 1 equiv) in dry dioxane (1.0 
mL) was added.  The resulting mixture was stirred and heated to 100 °C for 14 h.  The reaction 
was then cooled to ambient temperature and 1,3,5-trimethoxybenzene (7.03 mg, 0.0418 mmol) 
was added to the reaction mixture.  The reaction was quenched with sat. aq. NH4Cl (5 mL), 
extracted with EtOAc (5 mL x 2), the combined organic layers were washed with sat. aq. NaCl 
(10 mL), dried over Na2SO4, filtered, and concentrated to yield a yellow liquid.  The crude 
product mixture was analyzed by NMR and the yield of pyrrolidine 137a was determined 
relative to 1,3,5-trimethoxybenzene. NMR yield: 80% (average of two reactions) analytically 
pure samples of 137a were obtained via flash silica gel chromatography eluting with 2% 
EtOAc/98% hexanes.  Two rotamers of the title compound were observed by NMR 
spectroscopy.  1H NMR (CDCl3, 500 MHz):  = 7.33 - 7.41 (m, 4 H), 7.21 - 7.26 (m, 4 H), 7.15 
- 7.21 (m, 2 H), 3.31 (dt, J=11.0, 8.4 Hz, 1 H), 3.23 (dt, J=10.7, 8.3 Hz, 1 H), 2.92 - 3.06 (m, 2 
H), 2.47 - 2.57 (m, 1 H), 2.10 - 2.24 (m, 3 H), 1.90 (ddd, J=13.3, 9.9, 8.5 Hz, 1 H), 1.80 (ddd, 
J=13.2, 10.3, 8.3 Hz, 1 H), 1.58 (s, 9 H), 1.40 - 1.53 (m, 11 H), 1.34 - 1.40 (m, 1 H), 1.24 - 1.34 
(m, 2 H), 1.15 - 1.24 (m, 3 H), 0.99 - 1.07 (m, 1 H), 0.89 - 0.95 (m, 1 H), 0.69 - 0.80 (m, 9 H), 
0.63 - 0.69 ppm (m, 1 H); 13C NMR (CDCl3, 126 MHz):  = 154.8, 154.0, 145.5, 145.2, 132.0, 
131.7, 127.7, 127.5, 126.4, 126.3, 79.6, 78.2, 68.4, 67.8, 50.3, 50.2, 36.6, 35.0, 33.8, 33.7, 28.8, 
28.6, 26.2, 25.4, 21.7, 21.2, 12.5, 12.3, 8.3, 8.3, 8.2, 8.0 ppm; IR (thin film in DCM, cm-1): 
3053, 2983, 1691, 1666, 1421, 1390, 1365, 1265, 1170, 1118, 1070, 1028, 896, 748, 731, 705; 
HRMS (ESI): Product reacts via McLafferty rearrangement during analysis, calcd for 
C20H29NO2 [M-
tBu+ H]+:  260.1606; found 260.1609. 
 
tert-butyl 2-ethyl-2-(1-(3-nitrophenyl)cyclopropyl)pyrrolidine-1-carboxylate (137c): 
Prepared analogously to 137a.  NMR yield: 73% (average of two reactions) analytically pure 
samples of 137c were obtained via flash silica gel chromatography eluting with 5% EtOAc/95% 
hexanes. Two rotamers of the title compound were observed by NMR spectroscopy. 1H NMR 
(CDCl3, 500 MHz):  = 8.23 (t, J=2.0 Hz, 2 H), 8.07 (dd, J=7.3, 2.9 Hz, 2 H), 7.75 (d, J=7.8 Hz, 
1 H), 7.69 (d, J=7.8 Hz, 1 H), 7.37 - 7.45 (m, 2 H), 3.34 (dt, J=11.2, 8.3 Hz, 1 H), 3.23 (dt, 
J=10.9, 8.2 Hz, 1 H), 2.90 - 2.99 (m, 2 H), 2.45 - 2.55 (m, 1 H), 2.14 - 2.27 (m, 1 H), 2.06 - 2.14 
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(m, 1 H), 1.83 - 2.03 (m, 2 H), 1.59 (s, 7 H), 1.42 - 1.56 (m, 15 H), 1.39 (dt, J=9.8, 4.9 Hz, 1 H), 
1.09 - 1.28 (m, 4 H), 0.95 - 1.08 (m, 2 H), 0.68 - 0.82 ppm (m, 10 H); 13C NMR (CDCl3, 75 
MHz):  = 198.2, 154.5, 153.9, 147.6, 147.3, 138.1, 138.0, 128.6, 128.4, 126.6, 126.4, 121.7, 
121.6, 80.1, 78.7, 67.9, 67.4, 50.2, 50.0, 36.8, 35.3, 33.8, 33.4, 28.7, 28.5, 26.1, 25.2, 21.9, 21.4, 
12.8, 12.7, 8.8, 8.7, 8.1, 7.9 ppm; IR (thin film in DCM, cm-1): 3053, 2980, 2931, 2881, 1689, 
1529, 1477, 1467, 1454, 1421, 1390, 1365, 1352, 1265, 1170, 1136, 1120, 1072, 896, 736, 704; 
HRMS (ESI): Product reacts via McLafferty rearrangement during analysis, calcd for 
C20H28N2O4 [M-
tBu+ H]+: 305.1457; found 305.1457. 
 
 
 
tert-butyl 2-ethyl-2-(1-(4-methoxyphenyl)cyclopropyl)pyrrolidine-1-carboxylate (137b): 
Prepared analogously to 137a.  NMR yield: 74% (average of two reactions) analytically pure 
samples of 137b were obtained via flash silica gel chromatography eluting with 5% EtOAc/95% 
hexanes.  Two rotamers of the title compound were observed by NMR spectroscopy.  1H NMR 
(CDCl3, 500 MHz):  = 7.22 - 7.33 (m, 4 H), 6.73 - 6.82 (m, 4 H), 3.78 (d, J=4.4 Hz, 5 H), 3.31 
(dt, J=11.0, 8.2 Hz, 1 H), 3.23 (dt, J=10.9, 8.2 Hz, 1 H), 2.93 - 3.05 (m, 2 H), 2.44 - 2.54 (m, 1 
H), 2.08 - 2.23 (m, 3 H), 1.89 (ddd, J=13.2, 9.8, 8.3 Hz, 1 H), 1.79 (ddd, J=13.2, 10.0, 8.1 Hz, 1 
H), 1.54 - 1.60 (m, 9 H), 1.41 - 1.53 (m, 12 H), 1.33 - 1.41 (m, 1 H), 1.23 - 1.30 (m, 2 H), 1.13 - 
1.23 (m, 3 H), 0.95 - 1.02 (m, 1 H), 0.84 - 0.89 (m, 1 H), 0.75 (dt, J=11.2, 7.3 Hz, 6 H), 0.57 - 
0.71 ppm (m, 4 H); 13C NMR (CDCl3, 126 MHz):  = 158.3, 158.2, 155.0, 154.2, 137.9, 137.5, 
133.0, 132.8, 113.3, 113.0, 79.8, 78.4, 68.7, 68.1, 55.4, 50.5, 50.4, 36.8, 35.2, 33.1, 33.0, 29.0, 
28.8, 26.3, 25.6, 22.0, 21.4, 12.9, 12.6, 8.6, 8.6, 8.5, 8.3 ppm; IR (thin film in DCM, cm-1): 
3053, 2980, 2935, 2879, 1734, 1691, 1666, 1610, 1512, 1465, 1454, 1442, 1421, 1390, 1365, 
1290, 1265, 1246, 1172, 1132, 1118, 1070, 1033, 896, 835, 705; HRMS (ESI): Product reacts 
via McLafferty rearrangement during analysis, calcd for C21H31NO3 [M-
tBu+ H]+: 290.1711; 
found 290.1710. 
 
tert-butyl 2-ethyl-2-(1-(6-methoxynaphthalen-2-yl)cyclopropyl)pyrrolidine-1-carboxylate 
(137d): Prepared analogously to 137a.  NMR yield: 85% (average of two reactions) analytically 
pure samples of 137d were obtained via flash silica gel chromatography eluting with 5% 
EtOAc/95% hexanes.  Two rotamers of the title compound were observed by NMR 
spectroscopy. 1H NMR (CDCl3, 300 MHz):  = 7.56 - 7.78 (m, 6 H), 7.40 - 7.56 (m, 2 H), 7.05 
- 7.15 (m, 4 H), 3.87 - 3.94 (m, 6 H), 3.14 - 3.37 (m, 2 H), 2.85 - 3.04 (m, 2 H), 2.57 (dd, J=13.3, 
7.2 Hz, 1 H), 2.18 - 2.33 (m, 3 H), 1.75 - 1.99 (m, 2 H), 1.54 - 1.64 (m, 9 H), 1.15 - 1.54 (m, 19 
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H), 0.92 - 1.11 (m, 2 H), 0.69 - 0.87 ppm (m, 10 H); 13C NMR (CDCl3, 75 MHz):  = 157.5, 
157.4, 154.8, 154.0, 140.8, 140.4, 133.2, 133.2, 130.9, 130.5, 130.3, 130.1, 129.2, 129.2, 128.5, 
126.0, 125.7, 118.6, 118.5, 105.4, 79.6, 78.2, 68.5, 68.0, 55.3, 55.3, 50.2, 50.2, 36.6, 35.2, 33.7, 
33.5, 28.8, 28.6, 26.3, 25.4, 21.8, 21.3, 12.6, 12.5, 8.6, 8.5, 8.2, 8.0 ppm; IR (thin film in DCM, 
cm-1): 3053, 2984, 1692, 1668, 1605, 1422, 1389, 1366, 1265, 1209, 1163, 1032, 895, 739, 706; 
HRMS (ESI): Product reacts via McLafferty rearrangement during analysis, calcd for 
C25H33NO3 [M-
tBu+ H]+: 340.1868; found 340.1871. 
 
tert-butyl 2-ethyl-2-(1-(p-tolyl)cyclopropyl)pyrrolidine-1-carboxylate (137e): Prepared 
analogously to 137a.  NMR yield: 71% (average of two reactions) analytically pure samples of 
137e were obtained via flash silica gel chromatography eluting with 5% EtOAc/95% hexanes.  
Two rotamers of the title compound were observed by NMR spectroscopy. 1H NMR (CDCl3, 
500 MHz):= 7.21 - 7.29 (m, 4 H), 7.04 (t, J=7.3 Hz, 4 H), 3.32 (dt, J=11.0, 8.2 Hz, 1 H), 3.23 
(dt, J=10.7, 8.3 Hz, 1 H), 2.95 - 3.05 (m, 2 H), 2.46 - 2.57 (m, 1 H), 2.26 - 2.38 (m, 6 H), 2.08 - 
2.24 (m, 3 H), 1.88 (ddd, J=13.1, 9.9, 8.3 Hz, 1 H), 1.78 (ddd, J=13.1, 10.1, 8.1 Hz, 1 H), 1.52 - 
1.60 (m, 9 H), 1.37 - 1.51 (m, 12 H), 1.12 - 1.30 (m, 5 H), 0.97 - 1.06 (m, 1 H), 0.85 - 0.92 (m, 1 
H), 0.66 - 0.79 (m, 9 H), 0.59 - 0.66 ppm (m, 1 H); 13C NMR (CDCl3, 126 MHz):  = 158.1, 
158.0, 154.8, 153.9, 137.6, 137.3, 132.8, 132.5, 113.1, 112.8, 79.5, 78.2, 68.5, 67.9, 55.2, 50.2, 
50.1, 36.6, 35.0, 32.9, 32.7, 28.7, 28.6, 26.1, 25.4, 21.7, 21.2, 12.7, 12.4, 8.4, 8.4, 8.2, 8.0 ppm; 
IR (thin film in DCM, cm-1): 3053, 2980, 2930, 1692, 1668, 1514, 1454, 1422, 1391,1366, 
1265, 1171, 1119, 897, 739, 706, 473, 461, 453, 444, 438, 419, 409, 403; HRMS (ESI): Calcd. 
for C21H31NO2 [M-
tBu+ H]+: 247.1762; found 274.1765. 
 
tert-butyl 2-(1-(4-(tert-butyl)phenyl)cyclopropyl)-2-ethylpyrrolidine-1-carboxylate (137f): 
Prepared analogously to 137a.  NMR yield: 72% (average of two reactions) analytically pure 
samples of 137f were obtained via flash silica gel chromatography eluting with 2% EtOAc/98% 
hexanes.  Two rotamers of the title compound were observed by NMR spectroscopy. 1H NMR 
(CDCl3, 500 MHz):  = 7.20 - 7.34 (m, 8 H), 3.31 (dt, J=11.1, 8.1 Hz, 1 H), 3.21 - 3.28 (m, 1 
H), 2.98 - 3.06 (m, 2 H), 2.55 (dd, J=13.7, 6.8 Hz, 1 H), 2.06 - 2.24 (m, 3 H), 1.82 - 1.93 (m, 1 
H), 1.76 (ddd, J=13.1, 10.4, 7.8 Hz, 1 H), 1.55 - 1.59 (m, 9 H), 1.40 - 1.53 (m, 11 H), 1.15 - 1.35 
(m, 24 H), 1.01 - 1.09 (m, 1 H), 0.87 - 0.91 (m, 1 H), 0.68 - 0.79 (m, 9 H), 0.58 - 0.65 ppm (m, 1 
H); 13C NMR (CDCl3, 75 MHz):  = 154.8, 154.0, 149.2, 149.1, 142.2, 142.0, 131.5, 131.3, 
124.5, 124.3, 79.6, 78.2, 68.6, 67.9, 50.3, 50.2, 36.5, 34.7, 34.4, 34.4, 33.2, 33.2, 31.4, 31.4, 28.8, 
28.6, 26.2, 25.8, 21.6, 21.2, 12.4, 12.0, 8.3, 8.2, 8.1 ppm; IR (thin film in DCM, cm-1): 3053, 
2968, 2880, 1692, 1667, 1476, 1454, 1422, 1391, 1366, 1348, 1265, 1171, 1134, 1117, 895, 731, 
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706, 482, 474, 469, 461, 449, 434, 422, 417, 401; HRMS (ESI): Product reacts via McLafferty 
rearrangement during analysis, calcd for C24H37NO2 [M-
tBu+ H]+: 316.2232; found 316.2232. 
 
 
tert-butyl 2-ethyl-2-(1-(furan-3-yl)cyclopropyl)pyrrolidine-1-carboxylate (137g): Prepared 
analogously to 137a.  NMR yield: 73% (average of two reactions) analytically pure samples of 
137g were obtained via flash silica gel chromatography eluting with 2% EtOAc/98% hexanes.  
Two rotamers of the title compound were observed by NMR spectroscopy. 1H NMR (CDCl3, 
500 MHz):  = 7.26 - 7.29 (m, 2 H), 7.23 (s, 1 H), 7.25 (s, 1 H), 6.34 (d, J=1.1 Hz, 1 H), 6.30 (d, 
J=0.7 Hz, 1 H), 3.42 (dt, J=11.0, 7.5 Hz, 1 H), 3.32 (dt, J=10.9, 7.5 Hz, 1 H), 3.03 - 3.14 (m, 2 
H), 2.39 - 2.48 (m, 1 H), 2.07 - 2.23 (m, 3 H), 1.92 (dt, J=13.2, 8.2 Hz, 1 H), 1.84 (dt, J=13.2, 
8.4 Hz, 1 H), 1.50 - 1.60 (m, 13 H), 1.39 - 1.50 (m, 10 H), 1.08 - 1.22 (m, 4 H), 0.83 - 0.90 (m, 1 
H), 0.68 - 0.82 (m, 7 H), 0.52 - 0.67 ppm (m, 4 H); 13C NMR (CDCl3, 126 MHz):  = 154.7, 
153.8, 142.2, 141.8, 141.7, 141.5, 129.5, 129.3, 113.0, 112.6, 79.5, 78.3, 67.9, 67.2, 50.1, 37.7, 
35.9, 28.7, 28.6, 25.8, 25.3, 25.0, 24.6, 22.0, 21.7, 12.6, 11.9, 8.4, 8.3, 8.1 ppm; IR (thin film in 
DCM, cm-1): 3053, 2978, 2934, 2880, 1692, 1670, 1477, 1466, 1454, 1391, 1366, 1350, 1265, 
1173, 1161, 1123, 1072, 1065, 1018, 872, 797, 785, 770, 741, 704, 679, 602, 453, 444, 428, 422, 
415, 407 ; HRMS (ESI): Product reacts via McLafferty rearrangement during analysis, calcd for 
C18H27NO3 [M-
tBu+ H]+: 250.1398; found 250.1405. 
 
tert-butyl 2-heptyl-2-(1-phenylcyclopropyl)pyrrolidine-1-carboxylate (137i): Prepared 
analogously to 137a.  NMR yield: 80% (average of two reactions) analytically pure samples of 
137i were obtained via flash silica gel chromatography eluting with 2% EtOAc/98% hexanes.  
Two rotamers of the title compound were observed by NMR spectroscopy.  1H NMR (CDCl3, 
500 MHz):  = 7.37 - 7.41 (m, 2 H), 7.33 - 7.37 (m, 2 H), 7.20 - 7.26 (m, 4 H), 7.15 - 7.20 (m, 2 
H), 3.29 (dt, J=11.1, 8.1 Hz, 1 H), 3.21 (dt, J=10.7, 8.3 Hz, 1 H), 2.89 - 2.99 (m, 2 H), 2.42 - 
2.51 (m, 1 H), 2.23 (ddd, J=12.8, 8.4, 3.7 Hz, 1 H), 2.17 (ddd, J=12.6, 8.2, 3.7 Hz, 1 H), 2.06 - 
2.13 (m, 1 H), 1.92 (ddd, J=13.2, 9.8, 8.8 Hz, 1 H), 1.80 (ddd, J=13.1, 10.1, 8.1 Hz, 1 H), 1.58 
(s, 10 H), 1.38 - 1.52 (m, 11 H), 1.19 - 1.38 (m, 14 H), 0.98 - 1.19 (m, 8 H), 0.83 - 0.94 (m, 7 H), 
0.63 - 0.76 ppm (m, 4 H); 13C NMR (CDCl3, 126 MHz):  = 155.9, 154.8, 145.5, 145.2, 132.0, 
131.7, 127.7, 127.5, 126.4, 126.2, 79.6, 78.2, 68.1, 67.3, 50.2, 50.0, 37.4, 35.7, 34.9, 33.9, 33.8, 
33.7, 32.9, 32.1, 32.0, 30.0, 29.6, 28.8, 28.6, 23.9, 23.8, 22.7, 22.6, 21.8, 21.2, 14.1, 12.6, 12.3, 
8.3, 8.3 ppm; IR (thin film in DCM, cm-1): 3053, 2982, 2932, 2860, 1692, 1667, 1445, 1422, 
1391, 1366, 1265, 1169, 895, 706; HRMS (ESI): Product reacts via McLafferty rearrangement 
during analysis, calcd for C24H37NO2 [M-
tBu+ H]+: 316.2232; found 316.2235. 
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tert-butyl 2-hexyl-2-(1-(3-nitrophenyl)cyclopropyl)pyrrolidine-1-carboxylate (137j): 
Prepared analogously to 137a.  NMR yield: 76% (average of two reactions) analytically pure 
samples of 137j were obtained via flash silica gel chromatography eluting with 5% EtOAc/95% 
hexanes.  Two rotamers of the title compound were observed by NMR spectroscopy.  1H NMR 
(CDCl3, 500 MHz):  = 8.23 (t, J=2.0 Hz, 2 H), 8.05 - 8.10 (m, 2 H), 7.74 (d, J=7.8 Hz, 1 H), 
7.69 (d, J=7.8 Hz, 1 H), 7.37 - 7.45 (m, 2 H), 3.32 (dt, J=11.0, 7.9 Hz, 1 H), 3.22 (dt, J=11.0, 7.9 
Hz, 1 H), 2.90 (td, J=7.6, 4.4 Hz, 2 H), 2.39 - 2.49 (m, 1 H), 2.23 (ddd, J=13.1, 8.2, 4.2 Hz, 1 H), 
2.08 - 2.17 (m, 2 H), 2.01 (dt, J=13.9, 8.7 Hz, 1 H), 1.85 - 1.96 (m, 1 H), 1.60 (s, 8 H), 1.39 - 
1.54 (m, 14 H), 1.13 - 1.32 (m, 17 H), 1.02 - 1.12 (m, 5 H), 0.94 - 1.00 (m, 1 H), 0.82 - 0.91 (m, 
6 H), 0.70 - 0.82 ppm (m, 4 H); 13C NMR (CDCl3, 126 MHz): Shift = 154.5, 153.8, 147.8, 
147.7, 147.6, 147.3, 138.2, 138.0, 128.6, 128.3, 126.6, 126.3, 121.7, 121.6, 80.1, 78.7, 67.6, 66.9, 
50.1, 49.9, 37.6, 36.0, 33.9, 33.7, 33.5, 32.5, 32.0, 31.9, 29.9, 29.7, 29.5, 28.8, 28.5, 23.8, 23.7, 
22.7, 22.6, 21.9, 21.4, 14.0, 12.9, 12.7, 8.7, 8.7 ppm IR (thin film in DCM, cm-1): 3053, 2982, 
2963, 2930, 2872, 2860, 1690, 1672, 1530, 1477, 1454, 1422, 1391, 1366, 1352, 1302, 1265, 
1169, 1111, 1026, 895, 731, 706; HRMS (ESI): Product reacts via McLafferty rearrangement 
during analysis, calcd for C24H36N2O4 [M-
tBu+ H]+: 361.2083 ; found 361.2085. 
 
tert-butyl 2-hexyl-2-(1-(4-methoxyphenyl)cyclopropyl)pyrrolidine-1-carboxylate (137k): 
Prepared analogously to 137a.  NMR yield: 74% (average of two reactions) analytically pure 
samples of 137k were obtained via flash silica gel chromatography eluting with 2% EtOAc/98% 
hexanes. Two rotamers of the title compound were observed by NMR spectroscopy.  1H NMR 
(CDCl3, 500 MHz):  = 7.27 - 7.32 (m, 2 H), 7.22 - 7.26 (m, 2 H), 6.74 - 6.80 (m, 4 H), 3.75 - 
3.79 (m, 6 H), 3.29 (dt, J=11.0, 8.2 Hz, 1 H), 3.22 (dt, J=10.8, 8.1 Hz, 1 H), 2.90 - 2.99 (m, 2 H), 
2.40 - 2.48 (m, 1 H), 2.22 (ddd, J=12.9, 8.3, 4.0 Hz, 1 H), 2.11 - 2.18 (m, 1 H), 2.03 - 2.11 (m, 1 
H), 1.91 (dt, J=13.0, 9.2 Hz, 1 H), 1.75 - 1.83 (m, 1 H), 1.57 (s, 10 H), 1.38 - 1.49 (m, 11 H), 
1.22 - 1.37 (m, 15 H), 1.01 - 1.22 (m, 8 H), 0.95 - 1.00 (m, 1 H), 0.87 (q, J=7.2 Hz, 7 H), 0.57 - 
0.72 ppm (m, 4 H); 13C NMR (CDCl3, 126 MHz):  = 158.1, 158.0, 154.7, 153.9, 137.7, 137.3, 
132.8, 132.6, 113.1, 112.8, 79.5, 78.1, 68.2, 67.4, 55.2, 50.2, 50.0, 37.5, 35.7, 33.8, 32.9, 32.9, 
32.8, 32.1, 32.0, 30.0, 29.6, 28.8, 28.6, 23.9, 23.8, 22.7, 22.6, 21.8, 21.2, 14.0, 12.8, 12.4, 8.4 
ppm; IR (thin film in DCM, cm-1): 3053, 2980, 2961, 2932, 2872, 2860, 2839, 1734, 1692, 
1667, 1611, 1512, 1477, 1456, 1443,1422, 1391, 1366, 1319, 1288, 1265, 1246, 1171, 1134, 
1121, 1109, 1034, 895, 837, 731, 706, 474, 469, 457, 451, 442, 436, 422, 419, 415, 403 ; HRMS 
(ESI): Product reacts via McLafferty rearrangement during analysis, calcd for C25H39NO3 [M-
tBu+ H]+: 346.2337 ; found 346.2335. 
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isopropyl 2-ethyl-2-(1-phenylcyclopropyl)pyrrolidine-1-carboxylate (137m): Prepared 
analogously to 137a.  NMR yield: 80% (average of two reactions) Pure 137m was obtained via 
flash silica gel chromatography eluting with 2% EtOAc/98% hexanes.  Isolated yield: 45%  Two 
rotamers of the title compound were observed by NMR spectroscopy.  1H NMR (CDCl3, 300 
MHz):  = 7.29 - 7.44 (m, 2 H), 7.14 - 7.29 (m, 8 H), 5.01 - 5.15 (m, 1 H), 4.86 - 5.01 (m, 1 H), 
3.16 - 3.36 (m, 2 H), 3.00 (s, 2 H), 2.51 (s, 1 H), 2.17 (dd, J=13.3, 7.6 Hz, 3 H), 1.75 - 1.98 (m, 2 
H), 1.32 - 1.52 (m, 6 H), 1.16 - 1.32 (m, 14 H), 0.83 - 1.03 (m, 4 H), 0.64 - 0.79 ppm (m, 8 H); 
13C NMR (CDCl3, 75 MHz):  = 155.1, 154.3, 145.3, 145.1, 131.9, 131.7, 127.7, 127.5, 126.4, 
126.3, 68.7, 68.0, 68.0, 67.1, 50.4, 49.6, 36.7, 34.9, 33.6, 33.4, 29.7, 28.4, 25.9, 25.1, 22.5, 22.4, 
22.4, 21.8, 21.3, 12.9, 12.3, 8.4, 8.2, 8.2, 7.9 ppm; IR (thin film in DCM, cm-1): 3019, 2980, 
1686, 1655, 1530, 1400, 1385, 1352, 1317, 1215, 1111, 908, 772, 696, 669  HRMS (ESI): calcd 
for C19H27NO2 [M + H]
+: 302.2075; found 302.2073.   
 
isopropyl 2-ethyl-2-(1-(3-nitrophenyl)cyclopropyl)pyrrolidine-1-carboxylate (137n): 
Prepared analogously to 137a.  NMR yield: 86% (average of two reactions) analytically pure 
samples of 137n were obtained via flash silica gel chromatography eluting with 5% EtOAc/95% 
hexanes.  Two rotamers of the title compound were observed by NMR spectroscopy. 1H NMR 
(CDCl3, 300 MHz):  = 8.14 - 8.32 (m, 2 H), 8.05 - 8.11 (m, 2 H), 7.63 - 7.75 (m, 2 H), 7.37 - 
7.47 (m, 2 H), 4.88 - 5.19 (m, 2 H), 3.21 - 3.42 (m, 2 H), 2.88 - 3.05 (m, 2 H), 2.43 - 2.57 (m, 1 
H), 2.06 - 2.28 (m, 3 H), 1.84 - 2.06 (m, 2 H), 1.40 - 1.59 (m, 7 H), 1.21 - 1.34 (m, 11 H), 0.97 - 
1.21 (m, 6 H), 0.72 - 0.82 ppm (m, 10 H); 13C NMR (CDCl3, 75 MHz):  = 154.9, 154.2, 147.8, 
147.5, 147.2, 138.0, 138.0, 128.7, 128.4, 126.5, 126.3, 121.7, 121.6, 68.4, 68.3, 67.6, 50.3, 49.5, 
36.8, 35.2, 33.6, 33.3, 26.0, 24.9, 22.5, 22.3, 22.3, 21.9, 21.5, 13.0, 12.7, 8.8, 8.6, 8.1, 7.9 ppm; 
IR (thin film in DCM, cm-1): 3019, 2980, 1686, 1655, 1530, 1466, 1458, 1400, 1385, 1352, 
1317, 1215, 1179, 1111, 1070, 930, 908, 772, 696, 669, 471, 461, 440, 413, 403 ; HRMS (ESI): 
calcd for C19H26N2O4 [M + H]
+: 347.1926; found 347.1922. 
 
Isopropyl 2-ethyl-2-(1-(furan-3-yl)cyclopropyl)pyrrolidine-1-carboxylate (137o): Prepared 
analogously to 137a.  NMR yield: 81% analytically pure samples of 137o were obtained via 
flash silica gel chromatography eluting with 2% EtOAc/98% hexanes.  Two rotamers of the title 
54 
 
 
compound were observed by NMR spectroscopy. 1H NMR (CDCl3, 300 MHz):  = 7.23 (s, 4 
H), 6.29 (d, J=16.9 Hz, 2 H), 5.00 - 5.14 (m, 1 H), 4.92 (quin, J=6.2 Hz, 1 H), 3.31 - 3.50 (m, 2 
H), 3.06 - 3.20 (m, 2 H), 2.37 - 2.53 (m, 1 H), 2.05 - 2.28 (m, 3 H), 1.79 - 2.00 (m, 2 H), 1.39 - 
1.64 (m, 4 H), 1.36 (d, J=6.3 Hz, 3 H), 1.07 - 1.31 (m, 14 H), 0.53 - 0.90 ppm (m, 12 H); 13C 
NMR (CDCl3, 75 MHz):  = 155.0, 154.1, 142.2, 141.8, 141.8, 141.5, 129.4, 129.2, 112.9, 
112.6, 68.3, 68.0, 67.5, 67.2, 50.3, 49.6, 37.6, 35.9, 25.7, 25.0, 24.8, 24.5, 22.4, 22.2, 21.9, 12.8, 
12.0, 8.5, 8.4, 8.3, 8.1 ppm; IR (thin film in DCM, cm-1):3053, 2984, 1697, 1420, 1383, 1317, 
1265, 1111, 895, 872, 739, 706; HRMS (ESI): calcd for C17H25NO3 [M + H]
+: 292.1868; found 
292.1868. 
 
tert-butyl 2-methyl-2-(1-phenylcyclopropyl)pyrrolidine-1-carboxylate (137h): Prepared 
analogously to 137a.  NMR yield: 81% (average of two reactions) Analytically pure samples of 
137h were obtained via flash silica gel chromatography on silica deactivated silica gel eluting 
with 2% EtOAc/98% hexanes.  Silica was deactivated by preparing a slurry of silica gel in  2% 
NEt3/ 98% hexanes, then rinsing the column with EtOAc, then eluent twice.  Two rotamers of 
the title compound were observed by NMR spectroscopy.  1H NMR (CDCl3, 300 MHz):  = 
7.32 - 7.47 (m, 4 H), 7.15 - 7.26 (m, 5 H), 3.38 - 3.48 (m, 1 H), 3.27 - 3.38 (m, 1 H), 2.76 - 2.85 
(m, 1 H), 2.67 - 2.76 (m, 1 H), 2.27 - 2.39 (m, 2 H), 1.57 - 1.75 (m, 9 H), 1.44 - 1.57 (m, 12 H), 
1.31 - 1.43 (m, 6 H), 1.17 - 1.31 (m, 5 H), 0.66 - 0.90 ppm (m, 6 H); 13C NMR (CDCl3, 126 
MHz):  = 146.1, 128.0, 126.2, 125.9, 62.9, 40.5, 39.3, 33.9, 29.8, 26.9, 26.6, 23.2 ppm; IR 
(thin film in DCM, cm-1): 3053, 2974, 2870, 1690, 1389, 1169, 1265, 1061, 737; HRMS (ESI): 
Calcd for C19H27NO2 [M + H]
+: 302.2120; found 302.2120. 
 
Representative procedure for the deprotection of Boc-pyrrolidines: 
 
 
2-ethyl-2-(phenylcyclopropyl)pyrrolidine (138a):  Pyrrolidine 137a (100 mg, 0.3172 mmol) 
was dissolved in toluene (0.5 mL) followed by dropwise addition of 12 M HCl (0.5 mL). The 
reaction was heated to 70°C for 2 h. The reaction was cooled to ambient temperature and then 
transferred to a separatory funnel. The aqueous layer was separated and basified with saturated 
aqueous NaHCO3. The aqueous layer was then extracted with EtOAc, followed by washing and 
drying the organic layer with brine and Na2SO4. The crude material was concentrated under 
reduced pressure and purified on a plug of silica (10% EtOAC: Hex to 100% EtOAC) to yield 
deprotected free amine (38.07 mg, 56%). 1H NMR (CDCl3, 500 MHz):):  = 7.40 - 7.43 (m, 2 
H), 7.24 - 7.28 (m, 2 H), 7.17 - 7.21 (m, 1 H), 3.00 (dd, J=7.6, 4.2 Hz, 1 H), 2.87 - 2.94 (m, 1 H), 
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1.76 - 1.87 (m, 2 H), 1.68 (d, J=7.3 Hz, 1 H), 1.39 - 1.54 (m, 4 H), 0.92 - 0.97 (m, 4 H), 0.84 - 
0.88 (m, 1 H), 0.67 (ddd, J=9.3, 5.4, 3.9 Hz, 1 H), 0.58 ppm (ddd, J=9.2, 5.5, 3.4 Hz, 1 H); 13C 
NMR (CDCl3, 126 MHz):  = 145.4, 131.6, 127.6, 126.1, 66.1, 47.3, 34.5, 31.9, 31.2, 26.4, 9.7, 
8.9, 8.4 ppm; IR (thin film in DCM, cm-1): 3424, 3061, 2891, 1636, 766, 758;  HRMS (ESI): 
calcd for C15H21N [M + H]
+: 216.1747; found 216.1748.   
 
 
tert-butyl 2-ethyl-2-(1-(3-nitrophenyl)cyclopropyl)pyrrolidine-1-carboxylate (138b):  
Prepared analogously to 138a.  Yield: 54 mg, 75% of a clear orange liquid.  The crude material 
(54 mg, 0.208 mmol) was immediately dissolved in diethyl ether to which a solution of 4-
Nitrophenylacetic acid (37.7 mg, 0.208 mmol) in diethyl ether was added.  From the solution 
precipitated out clear needle-like crystals which were analyzed by X-ray diffraction (see below).  
 
Representative Procedure for the Synthesis of Piperidines 
 
 
6-ethyl-1-phenyl-2-azabicyclo[4.2.0]octane(161a): A mixture of Pd2dba3 (9.6 mg, 0.010 mmol 
2.5 mol%), XPhos (10 mg, 0.021 mmol, 5 mol%), Cs2CO3 (300 mg, 0.92 mmol, 2.2 equiv), and 
bromobenzene (0.088 mL, 0.84 mmol, 2.0 equiv) was prepared in a vial to which a solution of  
ACP 3a (100 mg, 0.418 mmol, 1 equiv) in dry dioxane (1.0 mL) was added.  The resulting 
mixture was stirred and heated to 100 °C for 14 h.  The reaction was then cooled to ambient 
temperature and filtered through a pad of celite with DCM.  The filtrate was concentrated, and 
the crude product was dissolved in DCM (0.75 mL) and the resulting solution was cooled to 0 °C 
in an ice water bath.  TFA (0.325 mL, 4.2 mmol, 10 equiv) was added to the cooled solution. 
And the reaction was allowed to stir at 0 °C for 1 h then allowed to warm to room temperature.  
The reaction was quenched with sat. aq. NaHCO3 (10 mL), the organic layer was diluted with 
DCM (5 mL) the layers were separated and the aqueous layer was extracted with DCM (2  x 5 
mL).  The combined organic layers were washed with sat. aq. NaCl (2 x 10 mL), dried over 
Na2SO4, filtered, and concentrated to yield an orange liquid. The crude material was purified via 
flash silica gel chromatography eluting with 40% EtOAc/60% hexanes with a gradient to 100% 
EtOAc.  Pure fractions were combined and concentrated to yield a yellow liquid. Yield: 48 mg, 
60% (average of two reactions) 1H NMR (CDCl3, 500 MHz):  = 7.29 - 7.37 (m, 2 H), 7.23 - 
7.28 (m, 1 H), 7.21 (dd, J=8.1, 1.2 Hz, 2 H), 4.80 (br. s., 1 H), 2.76 - 2.94 (m, 2 H), 2.38 - 2.47 
(m, 1 H), 2.23 - 2.33 (m, 1 H), 2.12 (ddd, J=10.9, 8.2, 2.4 Hz, 1 H), 1.83 - 1.98 (m, 1 H), 1.71 - 
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1.81 (m, 2 H), 1.61 (ddd, J=11.0, 8.5, 2.4 Hz, 1 H), 1.35 - 1.48 (m, 1 H), 1.15 - 1.33 (m, 2 H), 
0.69 - 0.80 ppm (m, 3 H); 13C NMR (CDCl3, 126 MHz):  = 143.2, 128.1, 126.9, 126.6, 64.1, 
42.9, 40.0, 30.7, 29.7, 29.0, 22.1, 21.7, 7.9 ppm; IR (Neat, cm-1): 2932, 1492, 1443, 1354, 1180, 
1143, 1086, 1053, 1026, 976, 851, 762, 701; HRMS (ESI): calcd for C15H21N [M+H]
+: 
216.1708 ; found 216.1706. 
 
6-ethyl-1-(6-methoxynaphthalen-2-yl)-2-azabicyclo[4.2.0]octane (161c): Prepared 
analogously to 161a. The crude material was purified via flash silica gel chromatography eluting 
with 40% EtOAc/60% hexanes with a gradient to 100% EtOAc.  Pure fractions were combined 
and concentrated to yield an orange solid. Yield: 62 mg, 68% (average of two reactions); 1H 
NMR (CDCl3, 500 MHz):  = 7.69 (dd, J=15.6, 8.3 Hz, 2 H), 7.56 (s, 1 H), 7.39 (dd, J=8.5, 1.7 
Hz, 1 H), 7.09 - 7.15 (m, 2 H), 3.91 (s, 3 H), 2.88 - 2.96 (m, 1 H), 2.80 - 2.88 (m, 1 H), 2.49 (dt, 
J=10.6, 8.6 Hz, 1 H), 2.28 (q, J=8.8 Hz, 1 H), 2.07 (ddd, J=10.7, 8.3, 2.4 Hz, 1 H), 1.81 - 1.92 
(m, 1 H), 1.73 - 1.81 (m, 2 H), 1.61 (ddd, J=10.7, 8.3, 2.4 Hz, 1 H), 1.57 - 1.70 (m, 1 H), 1.44 - 
1.54 (m, 1 H), 1.19 - 1.35 (m, 2 H), 0.75 ppm (t, J=7.3 Hz, 3 H); 13C NMR (CDCl3,  126 MHz): 
 = 157.35, 141.30, 133.16, 129.38,  128.72, 126.24, 126.02,  124.09, 118.67, 105.56, 63.43, 
55.31, 42.80, 40.67, 30.83, 30.42, 29.72, 23.05,  22.50, 8.02 ppm; IR (Neat, cm-1): 2959, 2938, 
2837, 1630, 1601, 1501, 1481, 1460, 1437, 1391, 1273, 1250, 1231, 1202, 1182, 1163, 1144, 
1126, 1028, 980, 962, 907, 899, 891, 853, 818, 743, 725, 698, 683, 629; HRMS (ESI): calcd for 
C20H25NO [M + H]
+: 296.1970 ; found 296.1978. 
 
 
 
6-ethyl-1-(p-tolyl)-2-azabicyclo[4.2.0]octane (161b): Prepared analogously to 161a. The crude 
material was purified via flash silica gel chromatography eluting with 40% EtOAc/60% hexanes 
with a gradient to 100% EtOAc.  Pure fractions were combined and concentrated to yield a 
yellow liquid. Yield: 41 mg, 48% (average of two reactions); 1H NMR (CDCl3, 500 MHz):  = 
7.12 (s, 4 H), 2.73 - 2.86 (m, 2 H), 2.31 - 2.39 (m, 4 H), 2.25 (q, J=9.1 Hz, 1 H), 1.95 (ddd, 
J=10.4, 8.2, 2.4 Hz, 1 H), 1.77 - 1.88 (m, 1 H), 1.68 - 1.77 (m, 2 H), 1.57 (ddd, J=10.5, 8.3, 2.2 
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Hz, 1 H), 1.32 - 1.41 (m, 1 H), 1.18 - 1.30 (m, 2 H), 0.75 ppm (t, J=7.3 Hz, 3 H); 13C NMR 
(CDCl3, 126 MHz):  = 142.9, 135.7, 128.6, 126.1, 63.2, 42.5, 40.4, 30.8, 30.3, 29.8, 23.0, 22.3, 
21.0, 8.0 ppm; IR (Neat, cm-1): 2935, 1511, 1460, 1441, 1377, 1354, 1182, 1141, 1112, 1040, 
1020, 977, 814, 779, 741, 727, 700; HRMS (ESI): calcd for C16H23N [M + H]
+: 230.1909; found 
230.1936. 
 
1-(4-(tert-butyl)phenyl)-6-ethyl-2-azabicyclo[4.2.0]octane (161d): Prepared analogously to 
161a. The crude material was purified via flash silica gel chromatography eluting with 20% 
EtOAc/80% hexanes with a gradient to 100% EtOAc.  Pure fractions were combined and 
concentrated to yield an orange liquid. Yield: 56 mg, 56% (average of two reactions); 1H NMR 
(CDCl3, 500 MHz):  = 7.29 - 7.33 (m, 2 H), 7.13 - 7.16 (m, 2 H), 2.75 - 2.86 (m, 2 H), 2.37 (dt, 
J=10.6, 8.6 Hz, 1 H), 2.21 - 2.30 (m, 1 H), 1.95 (ddd, J=10.4, 8.2, 2.4 Hz, 1 H), 1.77 - 1.87 (m, 1 
H), 1.68 - 1.77 (m, 2 H), 1.57 (ddd, J=10.6, 8.4, 2.4 Hz, 1 H), 1.33 - 1.41 (m, 1 H), 1.31 (s, 7 H), 
1.22 - 1.28 (m, 2 H), 0.72 - 0.78 ppm (m, 3 H); 13C NMR (CDCl3, 126 MHz):  = 148.8, 142.8, 
125.8, 124.7, 63.1, 42.6, 40.5, 34.3, 31.4, 30.8, 30.3, 29.8, 23.1, 22.3, 8.0 ppm; IR (Neat, cm-1): 
2961, 2876, 1510, 1461, 1442, 1400, 1362, 1269, 1142, 1110, 1010, 978, 909, 830, 730; HRMS 
(ESI): calcd for C19H29N [M + H]
+: 271.2334 ; found 271.2335. 
 
6-hexyl-1-phenyl-2-azabicyclo[4.2.0]octane (161f): Prepared analogously to 161a. The crude 
material was purified via flash silica gel chromatography eluting with 20% EtOAc/80% hexanes 
with a gradient to 100% EtOAc.  Pure fractions were combined and concentrated to yield an 
orange liquid. Yield: 60mg, 59% (average of two reactions); 1H NMR (CDCl3, 500 MHz):  = 
7.28 - 7.34 (m, 2 H), 7.19 - 7.24 (m, 3 H), 2.74 - 2.86 (m, 2 H), 2.33 - 2.44 (m, 1 H), 2.28 (q, 
J=9.0 Hz, 1 H), 1.97 (ddd, J=10.6, 8.2, 2.2 Hz, 1 H), 1.77 - 1.88 (m, 1 H), 1.67 - 1.77 (m, 2 H), 
1.58 (ddd, J=10.5, 8.3, 2.2 Hz, 2 H), 1.36 - 1.46 (m, 1 H), 1.07 - 1.31 (m, 10 H), 0.83 ppm (t, 
J=7.1 Hz, 3 H); 13C NMR (CDCl3, 126 MHz):  = 145.8, 127.9, 126.1, 126.1, 63.4, 42.4, 40.3, 
38.5, 31.9, 31.0, 30.2, 29.9, 23.9, 23.1, 23.0, 22.6, 14.0 ppm; IR (Neat, cm-1): 2928, 2855, 1492, 
1445, 1354, 1142, 1047, 1028, 981, 908, 763, 732, 702, 678; HRMS (ESI): calcd for C19H29N 
[M + H]+:   272.2334 ; found 271.2334. 
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6-methyl-1-phenyl-2-azabicyclo[4.2.0]octane (161e): Prepared analogously to 161a. The crude 
material was purified via flash silica gel chromatography eluting with 20% EtOAc/80% hexanes 
with a gradient to 100% EtOAc.  Pure fractions were combined and concentrated to yield an 
orange liquid. Yield: 39 mg, 52% (average of two reactions); 1H NMR (CDCl3, 500 MHz): 1H 
NMR  = 7.28 - 7.37 (m, 2 H), 7.17 - 7.25 (m, 3 H), 2.74 - 2.83 (m, 2 H), 2.36 - 2.51 (m, 2 H), 
1.93 - 2.00 (m, 1 H), 1.75 - 1.93 (m, 2 H), 1.66 - 1.75 (m, 1 H), 1.59 - 1.65 (m, 1 H), 1.47 - 1.57 
(m, 1 H), 1.34 - 1.43 (m, 1 H), 0.97 ppm (s, 3 H); 13C NMR (CDCl3, 126 MHz):  = 146.1, 
128.0, 126.2, 125.9, 62.9, 40.5, 39.3, 33.9, 29.8, 26.9, 26.6, 23.2 ppm  =; IR (thin film in 
CDCl3, cm-1): 2978, 2132, 1458, 1379, 1271, 1130, 1101, 1047, 1016, 907, 720, 650; MS: calcd 
for C19H29N [M]
+:   271.23 ; found 271.25. 
 
isopropyl 6-methyl-1-phenyl-2-azabicyclo[4.2.0]octane-2-carboxylate (161h): Pyrrolidine 
137m (76 mg, 0.2323 mmol) was dissolved in DCM (0.2 mL) and cooled to 0°C. TFA (0.2 mL) 
was added dropwise and the reaction was allowed to stir for 1 h in the ice bath. The reaction was 
basified with NaHCO3, extracted with DCM, and dried over Na2SO4. The organic layer was 
concentrated under reduced pressure and purified by column chromatography on silica gel (10% 
EtOAc: 90% Hex) to yield rearranged isopropyl protected piperidine (48.64 mg, 64%).  1H 
NMR (CDCl3, 500 MHz):  = 7.21 - 7.26 (m, 3 H), 7.06 - 7.21 (m, 2 H), 4.61 - 4.76 (m, 1 H), 
4.15 - 4.38 (m, 1 H), 3.07 - 3.18 (m, 1 H), 2.79 (dt, J=12.7, 8.3 Hz, 1 H), 2.40 (t, J=11.2 Hz, 1 
H), 1.89 - 2.04 (m, 2 H), 1.67 - 1.81 (m, 2 H), 1.57 - 1.66 (m, 1 H), 1.41 - 1.52 (m, 1 H), 1.14 - 
1.33 (m, 1 H), 1.11 (d, J=5.9 Hz, 3 H), 0.98 - 1.06 (m, 1 H), 0.86 (dd, J=13.4, 6.6 Hz, 1 H), 0.58 
- 0.71 ppm (m, 5 H); 13C NMR (CDCl3, 126 MHz):  = 156.6, 144.1, 127.4, 126.6, 126.0, 68.0, 
65.9, 44.5, 42.2, 29.6, 29.0, 28.5, 23.5, 22.1, 21.5, 20.2, 7.8 ppm; IR (thin film in DCM, cm-1): 
2963, 2876, 1676, 1383, 1265, 1111, 739, 704;  HRMS (ESI): calcd for C19H27NO2 [M + H]
+: 
302.2120; found 302.2115.   
 
 
 59 
APPENDIX B 
NMR SPECTRA 
FOR CHAPTER TWO
60 
 
EtNBocACP_Proton_J.esp
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
2.024.719.002.053.961.980.91
EtNBocACP_Carbon_J.esp
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
N
o
rm
a
li
z
ed
 I
n
te
ns
it
y
1
.3
3
1
.9
1
1
2
.4
2
2
7
.9
2
2
8
.3
7
3
2
.0
5
4
0
.4
9
7
6
.7
47
7
.0
0
7
7
.2
6
7
8
.8
7
1
1
4.
5
8
1
2
8.
4
8
1
5
5.
9
0
  
61 
 
 
Hexyl_PROTON_J.esp
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
2.943.956.1411.002.033.961.880.60
 
Hexyl_CARBON_J.esp
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
M02(s)
M03(s)
M04(s)
M05(s)
M06(s)
M08(s)
M10(s)
M11(s)
M12(s)
M17(s)
M19(s)
M20(s)
M13(s)
M07(s)
M09(s)
M18(s)
2
.1
9
1
4
.3
2
2
2
.8
9
2
7
.9
2
2
8
.6
5
2
9
.4
5
3
2
.0
2
3
2
.3
1
3
5
.1
1
4
0
.7
7
7
9
.1
7
1
1
5
.5
2
1
2
7
.4
9
1
5
6
.1
7
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KPF_iPr_ACP_proton_final_J.esp
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
6.586.042.213.871.980.811.04
 
KPF_Et_iPr_ACP_carbon.esp
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
1
.4
1
1
.9
7
1
2
.4
8
2
2
.1
8
2
7
.9
8
3
2
.0
6
4
0
.8
1
6
8
.0
6
1
1
4
.7
0
1
2
8
.4
6
1
5
6
.2
8
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MeNBocACP_PROTON_J.esp
9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
2.001.909.091.962.851.961.930.66
TMS
M05(t)
M02(m)M06(t)
M04(quin)
M03(s)
M07(m)
M08(br. s.)
M01(m)
0
.9
4
0
.9
5
0
.9
6
0
.9
6
1
.0
2
1
.0
3
1
.0
3
1
.4
4
1
.6
9
1
.7
0
1
.7
9
1
.8
0
1
.8
0
2
.1
7
2
.1
8
2
.2
0
3
.0
8
3
.0
9
3
.0
9
3
.1
0
3
.1
2
4
.5
2
 
MeNBocACP_CARBON_J.esp
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
M01(s)
M02(s)
M03(s)
M04(s)
M05(s)
M06(s)
M07(s)
M10(s)
M11(s)M12(s)
M13(s) TMS
1
.4
8
2
.8
3
2
0
.4
8
2
7
.6
9
2
8
.3
9
3
3
.7
4
4
0
.4
0
7
8
.9
0
1
1
5
.7
8
1
2
3
.2
2
1
5
5
.9
2
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PHBR_J.ESP
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
N
o
rm
a
liz
e
d
 I
n
te
n
s
ity
1.158.840.991.133.032.391.0011.379.380.990.852.991.012.001.020.931.853.823.69
PHBRCARBON_J_Power.esp
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.10
0.11
0.12
0.13
0.14
0.15
0.16
0.17
0.18
0.19
0.20
0.21
0.22
0.23
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
8
.0
1
8
.2
1
8
.2
4
8
.3
31
2
.2
4
1
2
.4
6
2
1
.1
4
2
1
.7
0
2
5
.4
3
2
6
.1
7
2
8
.5
8
2
8
.7
4
3
3
.6
4
3
3
.8
1
3
4
.9
7
3
6
.5
6
5
0
.1
4
5
0
.2
6
6
7
.7
9
6
8
.3
87
8
.2
2
7
9
.5
9
1
2
6
.2
5
1
2
7
.4
7
1
3
1
.7
2
1
3
1
.9
7
1
4
5
.2
0
1
4
5
.4
8
1
5
3
.9
6
1
5
4
.7
6
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3-NO2_J.ESP
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
10.021.974.280.8514.577.251.931.081.321.152.001.160.731.740.691.101.611.73
 
PRL4_250_B_FR12A-12C_CARBON_J.esp
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Chemical Shift (ppm)
0
0.005
0.010
0.015
0.020
0.025
0.030
0.035
0.040
0.045
0.050
0.055
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
7
.9
3
8
.1
1
8
.7
2
8
.8
0
1
2
.6
6
1
2
.8
1
2
1
.3
6
2
1
.8
5
2
5
.1
6
2
6
.1
1
2
8
.5
0
2
8
.7
5
2
8
.8
1
3
3
.4
5
3
5
.2
8
3
6
.8
0
5
0
.0
0
5
0
.1
6
6
7
.3
7
6
7
.9
3
7
7
.0
0
7
8
.7
3
8
0
.1
0
1
2
1
.5
9
1
2
1
.7
2
1
2
6
.5
61
2
8
.3
7
1
2
8
.6
3
1
3
7
.9
6
1
3
8
.1
5
1
4
7
.3
5
1
4
7
.6
4
1
5
3
.9
0
1
5
4
.5
2
1
9
8
.1
5
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4-MEO_PURE_J.ESP
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
N
o
rm
a
liz
e
d
 I
n
te
n
s
ity
4.195.910.981.023.052.171.1711.819.090.950.983.111.022.001.000.975.763.564.26
 
PRL4_257_B_PURE_CARBON_J.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
M30(s)
M01(s)
M02(s)
M03(s)
M04(s)
M05(s)
M06(s)
M07(s)
M08(s)
M09(s)
M11(s)
M12(s)
M13(s)
M14(s)
M15(s)
M16(s)
M17(s)
M18(s)
M19(s)
M20(s)
M21(s)
M25(s)
M26(s)
M27(s)
M28(s)
M29(s)
M31(s)
M33(s)
M32(s)
M34(s)
M36(s)
M35(s)
8
.0
2
8
.2
4
8
.3
7
1
2
.4
0
1
2
.7
0
2
1
.1
8
2
1
.7
4
2
5
.3
8
2
6
.0
6
2
8
.5
8
2
8
.7
5
3
2
.7
3
3
5
.0
0
3
6
.6
1
5
0
.1
4
5
0
.2
4
5
5
.1
7
6
7
.8
7
6
8
.4
6
7
8
.1
7
7
9
.5
4
1
1
2
.8
1
1
1
3
.0
5
1
3
2
.5
4
1
3
2
.7
9
1
3
7
.2
9
1
3
7
.6
3
1
5
3
.9
3
1
5
4
.7
6
1
5
8
.0
6
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6-MeO-Naphth_J.esp
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
9.931.8319.048.831.982.861.032.001.986.133.921.886.03
6-MeO-Naphth_carbon_J.esp
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
N
o
rm
a
li
z
ed
 I
n
te
ns
it
y
8
.0
38
.2
3
8
.4
9
1
2
.5
0
2
1
.2
92
1
.8
5
2
5
.4
2
2
6
.2
9
2
8
.6
2
2
8
.7
6
3
3
.5
4
3
3
.7
43
5
.2
2
3
6
.6
2
5
0
.1
5
5
0
.2
4
5
5
.2
8
6
8
.0
0
6
8
.5
1
7
6
.5
87
7
.0
0
7
7
.4
2
7
8
.2
3
7
9
.6
1
1
0
5.
4
2
1
1
8.
4
7
1
1
8.
6
0
1
2
5.
6
6
1
2
5.
9
8
1
2
9.
2
1
1
3
0.
8
8
1
3
3.
2
0
1
4
0.
4
4
1
4
0.
7
7
1
5
3.
9
9
1
5
4.
7
6
1
5
7.
4
2
1
5
7.
5
2
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4-MePhBr_J.esp
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
N
o
rm
a
liz
e
d
 I
n
te
n
s
ity
1.188.911.161.285.2611.919.131.091.023.426.021.042.001.000.963.543.90
4-MEPHBR_CARBON.ESP
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
N
o
rm
a
li
z
ed
 I
n
te
n
s
it
y
1
5
4.
9
9
1
5
4.
1
9 1
4
2.
7
2
1
4
2.
4
3
1
3
6.
1
8
1
3
5.
9
9
1
3
2.
0
3
1
3
1.
7
8
1
2
8.
6
2
1
2
8.
4
1
7
9
.7
6
7
7
.4
9
7
7
.2
3
7
6
.9
8
6
8
.6
9
6
8
.0
9
5
0
.4
1
3
6
.7
5
3
5
.1
3
3
3
.4
0
2
8
.9
6
2
8
.8
1
2
6
.4
7
2
5
.7
3
2
1
.9
4 2
1
.4
3
2
1
.2
6
1
2
.6
6
1
2
.4
6
8
.5
7
8
.4
8
8
.2
7
69 
 
 
PRL4_250_F_FR1C-2D_J.ESP
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
0.888.701.201.1224.1511.008.861.210.953.170.871.890.880.957.81
PRL4_250_F_PURE_CARBON_J.esp
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Chemical Shift (ppm)
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.10
0.11
0.12
0.13
0.14
0.15
0.16
N
o
rm
a
li
z
ed
 I
n
te
ns
it
y
0
.0
0
8
.0
5
8
.2
7
1
2
.4
3
2
1
.1
5
2
1
.6
2
2
5
.7
62
6
.1
5
2
8
.6
0
2
8
.7
6
3
1
.4
0
3
3
.2
5
3
6
.5
25
0
.2
6
6
7
.8
9
6
8
.5
9
7
7
.0
0
7
9
.5
5
1
2
4.
2
8
1
2
4.
5
3
1
3
1.
2
7
1
3
1.
5
2
1
4
1.
9
9
1
4
2.
2
5
1
4
9.
0
6
1
4
9.
2
5
1
5
3.
9
9
1
5
4.
8
2
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3-BRFURAN_J.esp
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
N
o
rm
a
liz
e
d
 I
n
te
n
s
ity
3.967.101.004.0710.1212.040.951.053.080.932.000.931.051.851.831.98
 
3-BrFuran-Carbon_J.esp
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
-0.05
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
8
.1
5
8
.3
2
1
1
.9
0
1
2
.5
82
1
.6
6
2
4
.9
7
2
5
.3
5
2
5
.7
6
2
8
.5
7
2
8
.7
4
3
5
.9
3
3
7
.6
6
5
0
.1
2
6
7
.1
6
6
7
.9
1
7
7
.0
0
7
9
.5
0
1
1
2
.6
4
1
1
3
.0
2
1
2
9
.3
0
1
2
9
.4
5
1
4
1
.4
91
4
1
.7
1
1
4
2
.2
2
1
5
3
.7
9
1
5
4
.6
7
 
71 
 
 
prl4_267_fr2C_Proton_J.esp
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
N
o
rm
a
liz
e
d
 I
n
te
n
s
ity
4.047.307.7414.1111.389.640.871.041.210.991.050.912.000.931.072.014.032.131.79
 
PRL4_267_FR2C_CARBON_J.esp
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.005
0.010
0.015
0.020
0.025
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
8
.2
5
1
2
.2
61
2
.5
6
1
4
.0
5
2
1
.1
9
2
3
.7
9
2
3
.9
3
2
8
.5
6
2
8
.7
8
2
9
.6
2
3
2
.1
1
3
3
.8
8
3
5
.6
6
3
7
.4
1
5
0
.0
45
0
.1
8
6
7
.3
4
6
8
.0
8
7
8
.1
9
7
9
.6
0
1
2
6
.2
3
1
2
6
.4
1
1
2
7
.4
6
1
2
7
.7
1
1
3
1
.7
3
1
3
2
.0
0
1
4
5
.1
8
1
4
5
.4
9
1
5
3
.8
9
1
5
4
.7
5
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prl4_268_pure_proton_J.esp
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
N
o
rm
a
liz
e
d
 I
n
te
n
s
ity
3.936.360.9521.1614.098.001.090.892.000.821.002.001.060.801.840.811.031.661.78
 
PRL4_268_PURE_CARBON_J.esp
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.005
0.010
0.015
0.020
0.025
0.030
0.035
0.040
0.045
0.050
0.055
N
o
rm
a
li
z
ed
 I
n
te
ns
it
y
8
.7
1
8
.7
6
1
2
.6
8
1
4
.0
4
2
1
.4
1
2
1
.8
9
2
2
.5
6
2
3
.7
8
2
8
.4
7
2
8
.7
7
2
9
.5
2
3
1
.9
3
3
2
.0
4
3
3
.7
5
3
5
.9
5
3
7
.6
4
4
9
.8
8
5
0
.0
6
6
6
.9
16
7
.6
1
7
8
.6
8
8
0
.0
8
1
2
1.
5
7
1
2
1.
7
1
1
2
6.
5
6
1
2
8.
3
4
1
2
8.
6
2
1
3
7.
9
6
1
3
8.
1
7
1
4
7.
3
1
1
4
7.
6
4
1
4
7.
7
4
1
4
7.
7
9
1
5
3.
8
4
1
5
4.
4
9
 
73 
 
 
4-MEOHEXYL_J.esp
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
4.027.361.0832.019.880.901.081.161.041.060.892.001.996.073.992.291.81
 
4-MEOHEXYL_CARBON_J.esp
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
8
.4
2
1
2
.7
7
1
4
.0
3
2
1
.2
4
2
2
.5
8
2
2
.6
7
2
3
.8
2
2
8
.5
6
2
8
.7
9
2
9
.9
5
3
2
.0
9
3
5
.6
8
3
7
.4
6
5
0
.0
4
5
0
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KPF_BrFur_final_J.esp
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MEPHNBOCPYRROLIDINE_COMBINED_PROTON_PURE.ESP
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Ph-Bycyclo__crude_proton_J.esp
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
3.072.140.971.042.090.910.960.940.931.851.041.931.101.90
 
Ph-Bycyclo_crude_carbon_J.esp
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
M01(s)
M02(s)
M05(s)
M06(s)
M07(s)
M08(s)
M09(s)
M12(s)
M13(s)
M14(s)
M15(s)
M03(s)
M04(s)
7
.8
7
2
1
.6
8
2
2
.0
5
2
8
.9
93
0
.7
0
3
9
.9
7
4
2
.9
2
6
4
.0
8
1
2
6
.5
5
1
2
8
.0
9
1
4
3
.1
7
 
79 
 
 
6MeONaphth_Pure_proton.esp
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4MePh-Bicyclo_Proton.esp
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4TBUPH-BICYCLO-PURE_PROTON_J.esp
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Hexyl-Ph-Bicyclo_PureProton_J.esp
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APPENDIX C 
EXPERIMENTAL INFORMATION 
FOR CHAPTER THREE 
88 
 
Unless otherwise noted all reactions were carried out in flame dried or oven dried glassware, 
under an atmosphere of Ar or N2.  All solvents and aryl halides were distilled from CaH2 and 
degassed by bubbling nitrogen through the liquid.  Palladium acetate was recrystallized from 
chloroform and hot filtration. Cyclopropyltriphenylphosphonium bromide, Herrmann-Beller 
palladacycle, and  ketones 186c and 186d were synthesized via the reported literature methods.S1-
S3  1H NMRs were obtained on either a Varian Inova 500 MHz NMR or a Varian Inova 300 MHz 
NMR (specified below for each compound), and referenced to an internal standard of TMS (= 
0.0 ppm).  13C NMRs were obtained from the previously mentioned instruments at either 126 
MHz or 75 MHz respectively and referenced to residual CHCl3 (= 77.0 ppm).  IRs were 
collected on a Thermo-Nicolet Nexus 470 FT-IR or a Shimadzu IRAffinity-1S FT-IR and 
reported in cm-1.   NMR yields were obtained by comparing the product to an internal standard of 
1,3,5-trimethoxybenzene, which was added to the crude reaction mixture prior to workup.  
 
References: 
S1: Utimoto, K.; Tamura, M.; Sisido, K. Tetrahedron 1973, 29, 1169–1171 
S2: Herrmann, W. A.; Brossmer, C.; Reisinger, C.-P.; Riermeier, T. H.; Öfele, K.; Beller, M. 
Chem. - A Eur. J. 1997, 3 (8), 1357–1364. 
S3: Fosso, M. Y.; Levine 3rd, H.; Green, K. D.; Tsodikov, O. V.; Garneau-Tsodikova, S. Org 
.          Biomol. Chem., 2015, 13, 9418-9426. 
 
 
 
 
Representative Procedure for the Synthesis of Pyridyl ACPs 
 
2-(1-cyclopropylideneethyl)pyridine (188a): In a glovebox of argon atmosphere, to a 100 mL 
RBF, a mixture of cyclopropyltriphenylphosphonium bromide (4.11 g, 10.7 mmol) and 
potassium tert-butoxide (1.20 g, 10.7 mmol) was suspended in toluene (25 mL). The flask was 
sealed and removed from the glovebox and placed under N2. Freshly distilled 2-acetylpyridine 
(1.00 g, 0.925 mL, 8.25 mmol) was added to the mixture which was allowed to stir and heat at 
100° for 1.5 h. At this time the reaction was cooled to ambient temperature and hexanes (50 mL) 
were added. The reaction was filtered and the filtrate was concentrated under reduced pressure. 
The previous two steps were repeated 3x. The crude red oil was distilled under vacuum to yield 
ACP 188a as a yellow oil (0.647 g, 54%).  1H NMR (CDCl3 ,500MHz):  = 8.48 - 8.70 (m, 1 
H), 7.81 (d, J=7.8 Hz, 1 H), 7.53 - 7.67 (m, 1 H), 7.01 - 7.18 (m, 1 H), 2.26 - 2.40 (m, 3 H), 1.40 
- 1.55 (m, 2 H), 1.13 - 1.31 ppm (m, 2 H); 13C NMR (CDCl3, 75MHz):  = 158.6, 148.6, 135.5, 
124.7, 124.5, 121.1, 120.6, 18.6, 5.8, 1.0 ppm; IR (thin film in DCM, cm-1): 3053, 2981, 2304, 
1697, 1587, 1265, 781, 738, 704; HRMS (ESI): calcd for C10H11N [M + H]
+: 146.0964; found 
146.0964.   
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2-(1-cyclopropylideneethyl)-6-methylpyridine (188b):. In a glovebox of argon atmosphere, to 
a 100 mL RBF, a mixture of cyclopropyltriphenylphosphonium bromide (5.15 g, 13.4 mmol) and 
potassium tert-butoxide (1.50 g, 13.4 mmol) was suspended in toluene (35 mL). The flask was 
sealed and removed from the glovebox and placed under N2. Freshly distilled 2-acetyl-6-
methylpyridine (1.39 g, 10.3 mmol) was added to the mixture which was allowed to stir and heat 
at 100° for 1.5 h. At this time the reaction was cooled to ambient temperature and hexanes (70 
mL) were added. The reaction was filtered and the filtrate was concentrated under reduced 
pressure. The previous two steps were repeated 3x. The crude oil was distilled under vacuum to 
yield ACP 188b as a white crystalline solid (0.312 g, 53%).  1H NMR (CDCl3, 500MHz):  = 
7.42 - 7.63 (m, 2 H), 6.96 (d, J=7.3 Hz, 1 H), 2.51 - 2.64 (m, 3 H), 2.25 - 2.37 (m, 3 H), 1.35 - 
1.54 (m, 2 H), 1.11 - 1.25 ppm (m, 2 H); 13C NMR (CDCl3, 75MHz):  = 158.1, 157.0, 135.6, 
124.9, 123.7, 120.3, 117.5, 24.6, 18.6, 5.6, 1.0 ppm; IR (thin film in DCM, cm-1): 3051, 2976, 
2304, 1585, 1571, 1454, 1265; HRMS (ESI): calcd for C11H13N [M+H]
+: 160.1121; found 
160.1121. 
 
 
 
 
2-(1-cyclopropylideneethyl)-3-methylpyridine (188c): In a glovebox of argon atmosphere, to a 
100 mL RBF, a mixture of cyclopropyltriphenylphosphonium bromide (3.68 g, 9.62 mmol) and 
potassium tert-butoxide (1.07 g, 9.62 mmol) was suspended in toluene (25 mL). The flask was 
sealed and removed from the glovebox and placed under N2. 2-acetyl-3-methylpyridine (1.00 g, 
7.40 mmol) was added to the mixture which was allowed to stir and heat at 100° for 1.5 h. At 
this time the reaction was cooled to ambient temperature and hexanes (50 mL) were added. The 
reaction was filtered and the filtrate was concentrated under reduced pressure. The previous two 
steps were repeated 3x. The crude oil was dissolved in a minimum of dichloromethane and 
loaded onto a column of silica gel and eluted with (95:5 Hex:EtOAc). Pure fractions were 
combined to yield ACP 188c as a pale, yellow oil (0.318 g, 27%).  1H NMR (CDCl3,500MHz): 
 = 8.42 (d, J=4.9 Hz, 1 H), 7.50 (d, J=8.3 Hz, 1 H), 7.07 (dd, J=7.6, 4.6 Hz, 1 H), 2.22 - 2.29 
(m, 6 H), 1.16 - 1.23 (m, 2 H), 1.05 - 1.12 ppm (m, 2 H); 13C NMR (CDCl3 ,126MHz):  = 
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160.4, 146.3, 138.0, 130.5, 126.4, 124.8, 121.4, 21.2, 19.3, 4.5, 2.0 ppm; IR (thin film in DCM, 
cm-1): 3053, 2985, 2304,1653, 1269; HRMS (ESI): calcd for C11H13N [M+H]
+: 160.1121; found 
160.1121.   
 
 
1-(1-cyclopropylideneethyl)isoquinoline (188d): In a glovebox of argon atmosphere, to a 100 
mL RBF, a mixture of cyclopropyltriphenylphosphonium bromide (1.45 g, 3.79 mmol) and 
potassium tert-butoxide (0.426 g, 3.79 mmol) was suspended in toluene (10 mL). The flask was 
sealed and removed from the glovebox and placed under N2. 1-acetylisoquinoline (0.500 g, 2.92 
mmol) was added to the mixture which was allowed to stir and heat at 100° for 1.5 h. At this 
time the reaction was cooled to ambient temperature and hexanes (20 mL) were added. The 
reaction was filtered and the filtrate was concentrated under reduced pressure. The previous two 
steps were repeated 3x. The crude oil was dissolved in a minimum of dichloromethane and 
loaded onto a column of silica gel and eluted with (90:10 Hex:EtOAc). Pure fractions were 
combined to yield ACP 188d as a yellow oil (0.152 g, 27%). 1H NMR (CDCl3, 500MHz):  = 
8.51 (d, J=5.9 Hz, 1 H), 8.02 (d, J=8.3 Hz, 1 H), 7.83 (d, J=7.8 Hz, 1 H), 7.66 (td, J=7.6, 1.0 Hz, 
1 H), 7.49 - 7.58 (m, 2 H), 2.40 - 2.45 (m, 3 H), 1.32 (td, J=7.6, 1.5 Hz, 2 H), 1.03 - 1.09 ppm 
(m, 2 H); 13C NMR (CDCl3, 126MHz):  = 162.5, 141.9, 136.8, 129.8, 127.6, 126.9, 126.5, 
126.2, 125.5, 123.8, 119.3, 21.6, 5.0, 2.7 ppm; IR (thin film in DCM, cm-1): 3053, 2980, 2306, 
1558, 1265, 734, 705; HRMS (ESI): calcd for C14H13N [M+H]
+: 196.1121; found 196.1121.  
 
Representative Procedure for the Synthesis of Indolizines 
 
2-benzyl-1-methylindolizine (189a): A mixture of Herrmann-Beller (11.7 mg, 0.012 mmol, 5 
mol%), CsF (0.151 g, 0.994 mmol, 4.0 equiv.), and bromobenzene (0.029 mL, 0.275 mmol, 1.1 
equiv.) was prepared in a vial to which a solution of ACP 188a (36.2 mg, 0.25 mmol, 1.0 equiv.) 
in dry toluene (0.3 mL) was added. The resulting mixture was stirred and heated to 110°C for 16 
h. The reaction was then cooled to ambient temperature and 1,3,5-trimethoxybenzene (4.20 mg, 
0.025 mmol, 10 mol%) was added to the reaction mixture. The reaction was quenched with sat. 
aq. NH4Cl (1 mL). The mixture was diluted with water (1 mL) and ethyl acetate (3 mL) and 
transferred to a separatory funnel where the organic layer was collected, dried over Na2SO4, 
filtered, and concentrated to yield a brown oil. The crude reaction mixture was analyzed by 
NMR and the yield of indolizine 189a was determined relative to 1,3,5-trimethoxybenzene. 
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NMR yield: 43% (average of two reactions). Analytically pure samples of 189a were obtained 
via flash silica gel column chromatography eluting in pure hexanes followed by fractional 
distillation under vacuum. The silica gel was deactivated prior to use by loading the column with 
2% triethylamine in hexanes, followed by a wash with ethyl acetate, and finally two washes of 
hexanes. 1H NMR (CDCl3, 500MHz):  = 7.70 - 7.74 (m, 1 H), 7.24 - 7.32 (m, 2 H), 7.15 - 7.23 
(m, 4 H), 6.97 (s, 1 H), 6.50 - 6.56 (m, 1 H), 6.28 - 6.34 (m, 1 H), 3.99 (s, 2 H), 2.22 ppm (s, 3 
H); 13C NMR (CDCl3, 126MHz):  = 141.3, 130.4, 128.7, 128.3, 127.3, 125.8, 124.7, 116.9, 
115.2, 110.6, 109.2, 106.5, 32.1, 8.6 ppm; IR (thin film in DCM, cm-1): 3053, 2983, 1265, 736, 
704; HRMS (ESI): calcd for C16H15N [M+H]
+: 222.1277; found 222.1277. 
 
 
2-(4-methoxybenzyl)-1-methylindolizine (189b): Synthesized analogously to 189a. NMR 
yield: 49% (average of two reactions). Analytically pure samples of 189b were obtained via flash 
silica gel column chromatography eluting in pure hexanes. The silica gel was deactivated prior to 
use by loading the column with 2% triethylamine in hexanes, followed by a wash with ethyl 
acetate, and finally two washes of hexanes. 1H NMR (CDCl3, 500MHz):  = 7.72 (d, J=6.8 Hz, 
1 H), 7.22 (d, J=8.8 Hz, 1 H), 7.13 (d, J=8.3 Hz, 2 H), 6.96 (s, 1 H), 6.79 - 6.85 (m, 2 H), 6.53 
(dd, J=9.3, 6.3 Hz, 1 H), 6.28 - 6.33 (m, 1 H), 3.93 (s, 2 H), 3.79 (s, 3 H), 2.21 ppm (s, 3 H); 13C 
NMR (CDCl3, 126MHz):  = 157.8, 133.4, 130.4, 129.6, 127.8, 124.7, 116.9, 115.2, 113.7, 
110.5, 109.1, 106.4, 55.3, 31.2, 8.6 ppm; IR (thin film in DCM, cm-1): 3053, 2985, 1510, 1265, 
736, 705; HRMS (ESI): calcd for C17H17NO [M+H]
+: 252.1388; found 252.1383. 
 
1-methyl-2-(3-nitrobenzyl)indolizine (189c): A mixture of palladium acetate (5.61 mg, 0.025 
mmol, 10 mol%), tri(o-tolyl)phosphine (7.60 mg, 0.025 mmol, 10 mol%), CsF (0.151 g, 0.994 
mmol, 4.0 equiv.), and 3-nitrobromobenzene (0.029 mL, 0.275 mmol, 1.1 equiv.) was prepared 
in a vial to which a solution of ACP 188a (36.2 mg, 0.25 mmol, 1.0 equiv.) in dry toluene (0.3 
mL) was added. The resulting mixture was stirred and heated to 110°C for 16 h. The reaction 
was then cooled to ambient temperature and 1,3,5-trimethoxybenzene (4.20 mg, 0.025 mmol, 10 
mol%) was added to the reaction mixture. The reaction was quenched with sat. aq. NH4Cl (1 
mL). The mixture was diluted with water (1 mL) and ethyl acetate (3 mL) and transferred to a 
separatory funnel where the organic layer was collected, dried over Na2SO4, filtered, and 
concentrated to yield a brown oil. The crude reaction mixture was analyzed by NMR and the 
yield of indolizine 189c was determined relative to 1,3,5-trimethoxybenzene. NMR yield: 43% 
92 
 
 
(average of two reactions). Analytically pure samples of 189c were obtained via flash silica gel 
column chromatography eluting with a gradient from pure hexanes to 10% EtOAC:90% Hex. 
The silica gel was deactivated prior to use by loading the column with 2% triethylamine in 
hexanes, followed by a wash with ethyl acetate, and finally two washes of hexanes. 1H NMR 
(CDCl3, 500MHz):  = 8.02 - 8.09 (m, 2 H), 7.76 (d, J=6.8 Hz, 1 H), 7.53 (d, J=7.3 Hz, 1 H), 
7.40 - 7.46 (m, 1 H), 7.24 (d, J=9.3 Hz, 1 H), 7.03 (s, 1 H), 6.57 (dd, J=8.8, 6.3 Hz, 1 H), 6.36 (t, 
J=6.6 Hz, 1 H), 4.09 (s, 2 H), 2.19 ppm (s, 3 H); 13C NMR (CDCl3,75MHz):  = 149.6, 143.5, 
134.8, 130.6, 129.1, 125.5, 124.8, 123.5, 121.1, 117.0, 115.7, 110.5, 109.6, 106.3, 31.8, 8.6 ppm; 
IR (thin film in DCM, cm-1): 3053, 2983, 1529, 1352, 1265, 736, 704; HRMS (ESI): calcd for 
C16H15N2O2 [M+H]
+: 267.1128; found 267.1128. 
 
 
1-methyl-2-(2,4,6-trimethylbenzyl)indolizine (189d): Synthesized analogously to 189a. NMR 
yield: 58% (average of two reactions). Analytically pure samples of 189d were obtained via flash 
silica gel column chromatography eluting in pure hexanes followed by fractional distillation 
under vacuum.  The silica gel was deactivated prior to use by loading the column with 2% 
triethylamine in hexanes, followed by a wash with ethyl acetate, and finally two washes of 
hexanes. 1H NMR (CDCl3, 500MHz):  = 7.58 (d, J=6.8 Hz, 1 H), 7.23 (d, J=9.3 Hz, 1 H), 6.89 
(s, 2 H), 6.51 (dd, J=9.0, 6.6 Hz, 1 H), 6.47 (s, 1 H), 6.25 (t, J=6.6 Hz, 1 H), 3.90 (s, 2 H), 2.34 
(s, 3 H), 2.30 (s, 3 H), 2.23 ppm (s, 6 H); 13C NMR (CDCl3, 126MHz):  = 136.6, 135.2, 134.8, 
129.6, 128.7, 126.7, 124.7, 116.6, 115.0, 109.9, 108.7, 107.8, 25.8, 20.9, 19.8, 8.5 ppm; IR (thin 
film in DCM, cm-1): 3053, 2981, 1263, 740, 704; HRMS (ESI): calcd for C19H22N [M+H]
+: 
264.1747; found 264.1747. 
 
 
2-benzyl-1,5-dimethylindolizine (189i): Synthesized analogously to 189a. NMR yield: 62% 
(average of two reactions). Analytically pure samples of 189i were obtained via flash silica gel 
column chromatography eluting in pure hexanes.  The silica gel was deactivated prior to use by 
loading the column with 2% triethylamine in hexanes, followed by a wash with ethyl acetate, and 
finally two washes of hexanes. 1H NMR (CDCl3, 500MHz):  = 7.16 - 7.30 (m, 9 H), 6.90 (s, 1 
H), 6.60 (dd, J=8.8, 6.3 Hz, 1 H), 6.25 (d, J=6.3 Hz, 1 H), 4.05 (s, 2 H), 2.40 (s, 3 H), 2.25 ppm 
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(s, 3 H); 13C NMR (CDCl3, 126MHz):  = 141.4, 132.2, 131.1, 128.6, 128.3, 127.2, 125.7, 
115.7, 114.5, 108.5, 107.5, 107.1, 32.2, 18.6, 8.8 ppm;  IR (thin film in DCM, cm-1): 3055, 
2985, 2922, 2362, 1265, 744, 704; HRMS (ESI): calcd for C17H17N [M+H]
+: 236.1434; found 
236.1434. 
 
 
 
2-(4-methoxybenzyl)-1,5-dimethylindolizine (189j): Synthesized analogously to 189a. NMR 
yield: 70% (average of two reactions).  Analytically pure samples of 189j were obtained via flash 
silica gel column chromatography eluting with a gradient from hexanes to 5% EtOAc:95% 
hexanes.  The silica gel was deactivated prior to use by loading the column with 2% 
triethylamine in hexanes, followed by a wash with ethyl acetate, and finally two washes of 
hexanes.  1H NMR (CDCl3, 500MHz):  = 7.21 (d, J=9.3 Hz, 1 H), 7.14 (d, J=8.8 Hz, 2 H), 
6.87 (s, 1 H), 6.80 - 6.85 (m, 2 H), 6.59 (dd, J=9.3, 6.3 Hz, 1 H), 6.24 (d, J=6.3 Hz, 1 H), 3.98 (s, 
2 H), 3.76 - 3.80 (m, 3 H), 2.39 (s, 3 H), 2.24 ppm (s, 3 H); 13C NMR (CDCl3, 126MHz):  = 
157.7, 133.6, 132.2, 131.2, 129.5, 127.7, 115.7, 114.5, 113.7, 108.5, 107.5, 107.0, 55.3, 31.3, 
18.6, 8.8 ppm; IR (thin film in DCM, cm-1): 3056, 2985, 1510, 1265, 740, 705; HRMS (ESI): 
calcd for C18H19NO [M+H]
+: 266.1539; found 266.1539. 
 
1,5-dimethyl-2-(3-nitrobenzyl)indolizine (189k): Synthesized analogously to 189a. NMR 
yield: 50% (average of two reactions).  Analytically pure samples of 189k were obtained via 
flash silica gel column chromatography eluting with a gradient from hexanes to 10% 
EtOAc:90% hexanes.  The silica gel was deactivated prior to use by loading the column with 2% 
triethylamine in hexanes, followed by a wash with ethyl acetate, and finally two washes of 
hexanes.  1H NMR (CDCl3, 500MHz):  = 8.09 (s, 1 H), 8.05 (d, J=7.8 Hz, 1 H), 7.54 (d, J=7.8 
Hz, 1 H), 7.43 (td, J=7.9, 1.7 Hz, 1 H), 7.23 (d, J=8.8 Hz, 1 H), 6.93 (s, 1 H), 6.60 - 6.66 (m, 1 
H), 6.29 (d, J=6.3 Hz, 1 H), 4.14 (s, 2 H), 2.42 (s, 3 H), 2.22 ppm (d, J=2.4 Hz, 3 H); 13C NMR 
(CDCl3, 126MHz):  = 148.4, 143.7, 134.8, 132.3, 131.4, 129.1, 125.5, 123.4, 121.0, 116.2, 
114.6, 109.0, 107.5, 107.0, 31.9, 18.6, 8.8 ppm; IR (thin film in DCM, cm-1): 3055, 2985, 1539, 
1354, 1265, 738, 705; HRMS (ESI): calcd for C17H16N2O2 [M+H]
+: 281.1285; found 281.1285. 
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2-benzyl-1,8-dimethylindolizine (189e):  Synthesized analogously to 189a except 2.5 
equivalents of aryl halide were required. NMR yield: 46% (average of two reactions).  
Analytically pure samples of 189e were obtained via flash silica gel column chromatography 
eluting with hexanes.  The silica gel was deactivated prior to use by loading the column with 2% 
triethylamine in hexanes, followed by a wash with ethyl acetate, and finally two washes of 
hexanes.  1H NMR (CDCl3, 300MHz):  = 7.58 (d, J=6.7 Hz, 1 H), 7.24 - 7.32 (m, 2 H), 7.15 - 
7.24 (m, 3 H), 6.92 (s, 1 H), 6.15 - 6.26 (m, 2 H), 3.96 (s, 2 H), 2.55 (s, 3 H), 2.44 ppm (s, 3 
H)13C NMR (CDCl3, 126MHz):  = 141.3, 130.2, 128.8, 128.7, 128.3, 127.3, 125.7, 123.2, 
116.1, 111.0, 109.0, 107.5, 32.0, 20.4, 11.1 ppm; IR (thin film in DCM, cm-1): 3055, 2933, 
1267, 742, 709; HRMS (ESI): calcd for C17H17N [M+H]
+: 236.1434; found 236.1434. 
 
  
 
 
2-(4-methoxybenzyl)-1,8-dimethylindolizine (189f): Synthesized analogously to 189a. NMR 
yield: 49% (average of two reactions).  Analytically pure samples of 189f were obtained via flash 
silica gel column chromatography eluting with a gradient from hexanes to 2% EtOAc:98% 
hexanes.  The silica gel was deactivated prior to use by loading the column with 2% 
triethylamine in hexanes, followed by a wash with ethyl acetate, and finally two washes of 
hexanes. 1H NMR (CDCl3, 500MHz):  = 7.60 (d, J=6.8 Hz, 1 H), 7.15 (d, J=8.3 Hz, 2 H), 6.92 
(s, 1 H), 6.85 (d, J=8.3 Hz, 2 H), 6.24 (s, 1 H), 6.21 (d, J=6.8 Hz, 1 H), 3.92 (s, 2 H), 3.80 (s, 3 
H), 2.57 (s, 3 H), 2.45 ppm (s, 3 H); 13C NMR (CDCl3, 126MHz):  = 157.8, 133.4, 130.2, 
129.6, 128.8, 127.8, 123.2, 116.1, 113.7, 111.0, 109.0, 107.4, 55.3, 31.1, 20.4, 11.1 ppm; IR 
(thin film in DCM, cm-1): 3043, 2922, 1508, 1267, 744, 704; HRMS (ESI): calcd for 
C18H19NO [M+H]
+: 266.1539; found 266.1539. 
   
95 
 
 
 
1,8-dimethyl-2-(3-nitrobenzyl)indolizine (189g): Synthesized analogously to 189a except 2.5 
equivalents of aryl halide were required. NMR yield: 43% (average of two reactions).  
Analytically pure samples of 189g were obtained via flash silica gel column chromatography 
eluting with a gradient from hexanes to 10% EtOAc:90% hexanes.  The silica gel was 
deactivated prior to use by loading the column with 2% triethylamine in hexanes, followed by a 
wash with ethyl acetate, and finally two washes of hexanes.  1H NMR (CDCl3, 500MHz):  = 
8.04 - 8.09 (m, 2 H), 7.63 (d, J=6.8 Hz, 1 H), 7.54 (d, J=7.3 Hz, 1 H), 7.44 (t, J=8.1 Hz, 1 H), 
6.99 (s, 1 H), 6.23 - 6.31 (m, 2 H), 4.08 (s, 2 H), 2.56 (s, 3 H), 2.42 ppm (s, 3 H); 13C NMR 
(CDCl3, 126MHz):  = 148.5, 143.6, 134.8, 130.5, 129.1, 129.0, 125.4, 123.5, 123.2, 121.1, 
116.6, 111.0, 109.5, 107.3, 31.7, 20.4, 11.1 ppm; IR (thin film in DCM, cm-1): 3055, 2926, 
1529, 1350, 1267, 748, 711; HRMS (ESI): calcd for C17H16N2O2 [M+H]
+: 281.1285; found 
281.1285. 
  
 
 
1,8-dimethyl-2-(2,4,6-trimethylbenzyl)indolizine (189h): Synthesized analogously to 189a. 
NMR yield: 58% (average of two reactions).  Analytically pure samples of 189h were obtained 
via flash silica gel column chromatography eluting with hexanes.  The silica gel was deactivated 
prior to use by loading the column with 2% triethylamine in hexanes, followed by a wash with 
ethyl acetate, and finally two washes of hexanes.  1H NMR (CDCl3, 500MHz):  = 7.45 (d, 
J=6.8 Hz, 1 H), 6.91 (s, 2 H), 6.40 (s, 1 H), 6.23 (d, J=6.3 Hz, 1 H), 6.14 (t, J=6.6 Hz, 1 H), 3.88 
(s, 2 H), 2.58 - 2.61 (m, 6 H), 2.32 (s, 3 H), 2.25 ppm (s, 6 H); 13C NMR (CDCl3, 126MHz):  = 
136.7, 135.2, 134.7, 130.0, 128.7, 128.5, 126.6, 123.2, 116.0, 110.2, 108.6, 107.1, 25.9, 20.9, 
20.5, 19.8, 11.0 ppm; IR (thin film in DCM, cm-1): 3055, 2983, 1421, 1267, 744, 704; HRMS 
(ESI): calcd for C20H23N [M+H]
+: 278.1903; found 278.1903. 
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2-benzyl-1-methylpyrrolo[2,1-a]isoquinoline (189l): Synthesized analogously to 189a except 
2.5 equiv. of bromobenzene was required. NMR yield: 36% (average of two reactions). 
Analytically pure samples of 189l were obtained via flash silica gel column chromatography 
eluting with hexanes.  The silica gel was deactivated prior to use by loading the column with 2% 
triethylamine in hexanes, followed by a wash with ethyl acetate, and finally two washes of 
hexanes.  1H NMR (CDCl3, 500MHz):  = 8.16 (d, J=8.3 Hz, 1 H), 7.57 (d, J=7.3 Hz, 1 H), 
7.50 (d, J=7.8 Hz, 1 H), 7.44 (td, J=7.8, 1.5 Hz, 1 H), 7.17 - 7.32 (m, 6 H), 6.93 (s, 1 H), 6.58 (d, 
J=7.3 Hz, 1 H), 4.03 (s, 2 H), 2.53 ppm (s, 3 H); 13C NMR (CDCl3, 126MHz):  = 141.3, 128.6, 
128.3, 127.8, 127.6, 126.9, 126.7, 126.1, 125.8, 124.6, 124.5, 122.4, 113.0, 111.5, 109.8, 31.8, 
12.2 ppm; IR (thin film in DCM, cm-1): 3062, 2980, 1641, 1261, 756, 704; HRMS (ESI): calcd 
for C20H17N [M+H]
+: 272.1434; found 272.1434. 
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6Me_ACP_proton.esp
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Chemical Shift (ppm)
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KPF_6Me_ACP_pure_carbon
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3Me_ACP_1H.esp
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Chemical Shift (ppm)
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isoquin_ACP_proton.esp
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Chemical Shift (ppm)
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2Ac_2Bn_Ph_ind_proton.esp
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Chemical Shift (ppm)
3.002.040.880.880.873.651.830.90
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2Ac_2Bn_4MeO_ind_proton.esp
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Chemical Shift (ppm)
3.013.142.140.870.861.890.861.870.890.90
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2Ac_2Bn_3NO2_ind_proton.esp
13 12 11 10 9 8 7 6 5 4 3 2 1 0 -1 -2 -3
Chemical Shift (ppm)
3.052.130.890.880.891.170.930.910.911.65
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2Ac_2Bn_3NO2_ind_carbon.esp
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2Ac_2Bn_Mes_ind_proton.esp
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Chemical Shift (ppm)
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2Ac_2Bn_Mes_ind_carbon.esp
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6Me_2Bn_PhBr_ind_proton.esp
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Chemical Shift (ppm)
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KPF_6Me_MeO_proton_final.esp
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Chemical Shift (ppm)
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6me_2Bn_4MeO_ind_carbon.esp
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6Me_2Bn_3NO2_ind_proton.esp
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Chemical Shift (ppm)
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KPF_3Me_Ph_proton_final
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3Me_2Bn_ind_4MeO_proton.esp
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Chemical Shift (ppm)
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3Me_2Bn_ind_3NO2_proton.esp
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RRK_3Me_Mes_proton_final.esp
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isoquin_2Bn_proton.esp
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